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ABSTRACT
Ankyloblepharon- Ectodermal defects Cleft lip/palate (AEC) syndrome, also 
known as Hay-Wells syndrome, is a severe genetic disorder caused by 
mutation in p63 gene and characterized by congenital erythroderma and severe 
skin erosions in infants that resolve very slowly leaving scars. To identify 
molecular mechanisms underlying the severe skin defects, we generated a 
conditional knock-in mouse carrying an inducible p63 mutation (L514F). AEC 
conditional mutant mice showed a strong phenotype including focal skin 
erosions, crusting and complete hair loss. A high percentage of mutant mice 
died between 8 and 15 days after birth. Epidermis was hyperplastic and 
hyperkeratotic, and massive infiltration of macrophages and mast cells was 
observed in the dermis. At the molecular level, reduced mechanical stress 
resilience was accompanied with a progressive skin inflammation due to 
strongly elevated level of Thymic stromal lymphopoietin (Tslp), an IL-7 like 
cytokine. Epidermal-derived Tslp was circulating in the bloodstream, causing a 
dramatic expansion of immature B-cells (pre B-cells) in the bone marrow and 
spleen, leading to the insurgence of an autoimmune lymphoproliferative 
disorder. Genetic ablation of Tslp in the epidermis ameliorated the general 
health condition of mutant mice, significantly reducing skin inflammation,
rescuing B-cell differentiation, and increasing survival in AEC mice. 
Mechanistically, massive Tslp release was accompanied by strong induction of 
kallikrein-6 (Klk6) and NFAT accumulation in mutant epidermis. Klk6 is 
repressed by wild-type p63 in epidermis and NFAT overexpression strongly 
induced Tslp in keratinocytes. Taken together these data indicate that in AEC
mutant epidermis, Klk6 upregulation leads to massive Tslp induction by an
NFAT-dependent mechanism. We propose that since extended skin erosions in 
AEC patients can also be associated with an autoimmune proliferative disorder, 
controlling Tslp in severely affected patients may be therapeutically beneficial. 
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1. BACKGROUND
1.1 The skin: the body natural barrier
The skin performs many important functions: protect us from trauma,
ultraviolet radiation, microorganisms and chemicals agents. Prevents the loss 
of liquid; participates in the mechanism of thermoregulation, increasing 
(vasodilatation) or slowing down (vasoconstriction) the dispersion of heat. 
It is composed of three main layers that from the outside inwards are:
epidermis, dermis and hypodermis (subcutaneous layer). 
The epidermis is the outermost layer of the skin, composed of a stratified 
squamous epithelium that rest on top of a basement membrane, rich in 
extracellular matrix, which separate it and its appendages, including the hair 
follicles and sweat glands from the underlying dermis. The epidermis and its 
appendages provide a protective barrier. It has a thickness comprised between 
50 µm and 1.5 µm. The epidermis is composed of 4 layers: the cornified layer 
also known like stratum corneum, granular layer, spinous layer and basal layer 
(Fig. 1). The stratified squamous epithelium of the epidermis is maintained by 
cell division within the basal layer. During the epidermal maturation the cells 
undergo a complex series of morphological and biochemical changes that 
result in the production of the stratum corneum, the highly cornified outermost 
layer of the tissue composed by cornified cell envelopes assembled by cross-
linking of structural proteins and lipids.  More in detail, the cells of the basal 
layer remain attached to an underlying matrix through a series of adhesion 
molecules such as hemidesmosomes, laminin and anchoring fibrils, and
proliferate. Some of their daughter keratinocytes enter the spinous layer 
through asymmetric mitoses, where they exit the cell cycle, grow larger and 
establish robust intercellular connections (Simpson et al, 2011). The cells 
switch expression of basal layer specific keratins, Keratin5 (Krt5) and Keratin 
14 (Krt14), to Keratin1 and Keratin10 (Krt1; Krt10) typical of the spinous
layer (Fuchs & Green, 1980). In addition other keratins are also expressed 
suprabasally, as Keratin6 (Krt6), Keratin16 (Krt16) and Krt17 (Krt17), but 
only in hyperproliferative condition such as wound healing. The spinous layer
also contains Langerhans cells, which are derived from a precursor in bone 
marrow and are involved in immune response. Above the spinous layer, 
keratinocytes contain numerous keratohyalin granules packed with the protein 
profilaggrin in their cytoplasm, hence the name “stratum granulosum”. Cells in 
the granular layer flatten and assemble a water-impermeable cornified 
envelope underlying the plasma membrane and express filaggrin (Flg) and
loricrin (Lor) as markers. In addition, cornified envelope proteins, which are 
rich in glutamine and lysine residues, are synthesized and deposited under the 
plasma membrane of the granular cells. As response to the increased 
permeability to the calcium, the cells activate transglutaminase, generating γ-
glutamyl ε-lysine crosslinks to create an indestructible barrier. Finally, stratum 
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corneum keratinocytes release lysosomal enzymes to degrade major organelles, 
including the nucleus. The final steps of terminal differentiation involve also 
the extrusion of lipid bilayers, packaged in lamellar granules, onto the scaffold 
of the cornified envelope. The dead stratum corneum cells create an 
impenetrable layer that is continually replaced (Fuchs, 2007).
Keratinocytes move from the proliferative basal layer through the granular 
layer and continually replaced the cells of the outward layers. Indeed, as the 
body’s outer frontier, the epidermis is subject to repeated trauma that must be
repaired after wounding (Shen et al, 2013). Within this layer, epidermal stem 
cells divide to self-renew and produce transient amplifying (TA) cells, which 
are able of a more limited proliferative capacity. Transit amplifying cells 
constitute the major cell type in the basal layer of the developing and mature 
epidermis and after few rounds of cell division they exit from the cell cycle, 
and initiate a terminal differentiation program, as they migrate outward toward 
the tissue surface. 
Figure 1. The epidermis. The epidermis is a stratified squamous epithelium 
composed by the indicated layers: the basal layer on top of the basement 
membrane consisting of proliferating, transit-amplifying cells interspersed to 
epidermal stem cells; spinous layer, granular layer and the cornified layer. 
Upon withdrawal from the cell cycle, basal keratinocytes detach from the 
basement membrane and undergo a terminal differentiated program to become 
corneocytes in the outer layers of the epidermis. The gene mainly expressed in 
the basal layer is p63, the master regulator of epidermal development. In the
intermediate stratum spinosum, the cells reinforce their keratin filament 
network, and adjacent cells interact via many desmosomes. In the stratum 
granulosum, keratinocytes become more flattened and express certain proteins 
such as filaggrin and loricrin, which aggregate to form the typical keratohyalin




1.2 p63, the master regulator of epidermal gene expression: structure and 
function
p63 belongs to the p53 gene family consisting of three genes, p53, p63, and 
p73, that show significant homology (Yang et al, 2002). They share three 
functional domains: an N-terminal transactivation domain which shares 25% 
homology with N-terminal part of p53, a central DNA binding domain which 
shares 65% of homology with the corresponding p53 domain and C-terminal
tetramerization domain, which shares 35% of homology with the 
oligomerization domain of p53 (Yang et al, 2002). In addition, all family 
members share some functions and bind to a canonical p53-binding site, thus 
controlling the expression of a subset of p53 target genes (Fig 2). p63, p53 and 
the third member p73, constitute a family of key transcriptional regulators in 
cell growth, differentiation and apoptosis. Indeed, while p53 is a major player 
in tumorigenesis (Kemp et al, 1994), p63 and p73 are involved in embryonic 
development (Mills et al, 1999; Yang et al, 2000). p63 has a crucial role in 
embryonic development of stratified epithelia where it can function either as an 
activator or a repressor (Koster & Roop, 2004; LeBoeuf et al, 2010). In
particular, p63 is a master regulator of epidermal gene expression and it is 
critical for cell proliferation (Antonini et al, 2010; Senoo et al, 2007; Truong et 
al, 2006), cell adhesion (Carroll et al, 2006; Koster et al, 2007) and
stratification (Koster & Roop, 2004; Truong et al, 2006) while suppressing
terminal differentiation (Nguyen et al, 2006).
The p63 gene encodes a tetrameric factor that can be expressed in at least six 
isoforms with widely different transactivation potential that share an identical 
DNA binding domain (Yang et al, 1998). p63 is composed of 16 exons located 
on chromosome 3q28 and it has two independent transcriptional start sites that 
give rise to two different N-terminal isoforms: TA and ΔN that in turn produce 
α, ß or γ ends as the result of alternative splicing events towards the C-terminal
region. In particular, TAp63 contains an acidic N-terminal transactivation 
domain similar to the one found in the canonical full-length p53. TAp63 is 
expressed at very low levels in most tissues, whereas it is constitutively 
expressed in female germ cells where it is activated by phosphorylation upon 
DNA damage, inducing oocyte death (Gonfloni et al, 2009; Kerr et al, 2012;
Suh et al, 2006). In contrast ∆Np63 is widely expressed in the basal 
regenerative layer of the epidermis and other stratified epithelia, (Yang et al, 
1998). ∆Np63 is the most abundant protein in the epidermis whereas the 
TAp63 is barely detectable by RNA-seq (Rizzo et al, 2014). The first 26 amino 
acids of the N-terminal region in ∆Np63 are required for its transcriptional 
activity, together with the proline-rich domain (PR) and a domain (TA2) 
located between the OD and the sterile-α-motif (SAM) domain (Dohn et al, 
2001; Ghioni et al, 2002; Helton et al, 2006). The main isoform expressed in 
stratified epithelia is the p63α that contains at the C-terminal end a SAM 
domain and a post-SAM domain (PS) absent in p63ß, p63γ, or in p53 (Yang et 
al, 1998). SAM domains have several functions; they can interact with 
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themselves, bind to other SAM domains, bind to non–SAM domain proteins, 
or to RNA (Qiao & Bowie, 2005). p63’s SAM domain is a five helical bundle 
domain that is unable to form homodimers (Chi et al, 1999; McGrath et al, 
2001) and its function remains uncovered. The PS domain, also known as 
transcriptional inhibitory domain (TID), consists of two regions. The former
interacts with the TA domain of another TAp63 molecule, establishing a closed 
and inactive dimer that can be activated by phosphorylation, resulting in an 
active tetramer (Deutsch et al, 2011; Su et al, 2010). The latter region holds
p63 protein concentration via a sumoylation-dependent mechanism (Straub et 
al, 2010). However, the functional role of the PS domain is poorly understood.
Figure 2. Functional domains and isoforms of the p53 family proteins.
Comparison between p53 and p63 proteins. Conserved protein domains are: 
TA, Trans-Activation domain; DNA binding domain; Oligomerization domain;
SAM, Sterile- α -motif domain; PS, Post-SAM domain.  TA, isoforms are
transcribed from the upstream promoter; and ΔN, isoforms transcribed from 
the cryptic promoter within intron 3. The percentage of identity is indicated for 
each domain. 
1.3 p63-deficient mice 
In the 1999, two independent groups obtained a p63-deficient mouse model.
Using these models they could explore the unique roles of p63 in development
of ectodermal derived tissues. p63-/- mice die for dehydration soon after birth 
and display severe defects of all stratified epithelia and their derivatives, facial 
clefting and impaired limb formation, suggesting that p63 plays a pivotal role
in these tissues (Mills et al, 1999; Yang et al, 1999). Defects in the surface 
epithelium of p63-/- mice have been ascribed to loss of proliferative potential of 
keratinocyte stem cells (Senoo et al, 2007; Yang et al, 1999), and/or altered 
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epidermal stratification and cell differentiation associated with reduced 
expression levels of Krt5/Krt14 and Krt1/Krt10 (Koster & Roop, 2004; Mills et 
al, 1999; Romano et al, 2009). p63-deficient newborns show striking limb 
defects. The fore limbs were truncated and hind limbs were completely absent 
and the structures dependent upon epidermal-mesenchymal interactions during 
embryonic development, such as hair follicles, teeth and mammary glands, are 
absent. Phalanges and carpals were absent in both the p63-homozygous
mutant, whereas more proximal forelimb structures were slightly 
heterogeneous in the extent of the truncation in the two models. The femur and 
all distal skeletal elements were also absent. These defects are caused by a 
failure of the apical ectodermal ridge (AER) to differentiate. The lack of a 
proper AER limb buds in p63 null mice results from a failure of the ectoderm 
to undergo growth and differentiation that give rise to this stratified epithelium.
Indeed, several genes that are important in limb-bud outgrowth are not 
expressed, such as Fgfr8, a marker of the AER, and Msx-1 which expression in 
the mesenchyme depends on an ectodermal signal, or abnormally expressed, 
such as Lmx-1, a marker of the dorsal limb mesenchyme (Mills et al, 1999; 
Yang et al, 1999).
The skin in the knock-out mouse model generated by McKeon’s group lacks
expression of the basal layer markers as Krt5 and Krt14 and also spinous layer
markers Krt1 and Krt10. Even though, isolated patch of the epidermis showed 
the expression of late differentiation markers such as Loricrin, Involucrin and 
Filaggrin. The authors prove that p63 is required for the initial development 
and continued regeneration of the epidermis and that the loss of p63 in the 
tissues failed to maintain the proliferative potential of stem cells in skin (Fig.
3) (Yang et al, 1999). In addition, to reinforce this hypothesis the same authors 
in another study demonstrate that p63 is fundamental to maintain the 
proliferative potential of epithelia stem cells of both thymus and epidermis 
(Senoo et al, 2007).
?
Figure 3. Phenotype of p63 knock out mouse generated by McKeon’s 
group. A) The newborn p63 null mice show defects in skin stratification, limb
formation and craniofacial defects. B) H&E staining of the skin at E17 display
p63-/- mice lacking squamous stratification in the epidermis compared to wild-








The p63 knock out mice generated by Mills’s group developed aberrant skin 
and appendages due to lack of stratification and differentiation (Fig. 4)(Mills et 
al, 1999). The authors showed that in p63 null mice all structures that required
the ectodermal mesenchymal signal were compromised because the ectoderm 
failed to receive the signal. They showed that the skin of p63 null mice were
covered by a single disorganized layers of ectodermal cells or flattened
epidermal cells in which they did not detect the expression of any early or late 
differentiation markers. Their results suggested that p63 is the determining
factor of stratification, and supported the hypothesis that p63 is required for
simple epithelial cells to commit to a stratified epithelial lineage during 
development (Mills et al, 1999).
Figure 4. The phenotype of p63-deficent newborn mice generated by 
Mills’s group. A) p63 null mice show severe limb and skin defects. B) 
Expression of different markers in the epidermis of p63 null mice: staining for 
Krt14 in red and Krt1 and Filaggrin (Fil) in green. Krt14 is weakly express in 
p63 null mice, whereas Krt1 and Fil are not detectable in the epidermis 
(Adapted from Mills et al., 1999).
1.4 p63-associated disorders
The crucial role of the transcription factor p63 in the formation of the 
epidermis and other stratifying epithelia is demonstrated by two lines of 
evidence. First, p63-deficient mice have no epidermis and aberrant squamous 
epithelia, and are also devoid of epithelial appendages, such as hair follicles 
and teeth. Second, heterozygous mutations in the human p63 gene are 
responsible for several ectodermal dysplasia (ED) syndromes, which are 
congenital disorders characterized by abnormalities of two or more ectodermal 
structures, such as hair, nails, sweat glands and digits. p63 expression is 
highest in the proliferative basal cell layer where epithelial progenitor cells are 
thought to reside in a range of stratified epithelia, including skin, in particular 
BA
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in the nuclei of basal cells of the skin, cervix, tongue, esophagus, mammary 
glands, prostate and urothelium (Carroll et al, 2007).
Mutations in the p63 gene can cause at least five different syndromes: 
Ectrodactyly- Ectodermal defects-Cleft lip/palate syndrome (EEC, OMIM
604292), Ankyloblepharon- Ectodermal defects-Cleft lip/palate syndrome 
(AEC, OMIM 106260), Limb Mammary Syndrome (LMS, OMIM 603543),
Acro- Dermato- Ungual- Lacrimal- Tooth syndrome (ADULT, OMIM 103285)
and Rapp-Hodgkin Syndrome (RHS, OMIM 129400). Furthermore, two non-
syndromic human disorders are caused by p63 mutations: isolated split 
hand/foot malformation (SHFM4, OMIM 605289) and recently non-syndromic
cleft lip. 
EEC syndrome is mainly caused by point mutation in the DNA binding 
domain (DBD) of the p63 gene. EEC syndrome comprises limb malformation, 
ectodermal dysplasia and orofacial clefting. Representative limb malformation 
are ectrodactyly and syndactyly (Rinne et al, 2007). Ectodermal dysplasia is 
seen as lightly colored, sparse hair and can be observed absence of eyelashes, 
eyebrows and alopecia. Skin is thin and dry, sometimes resembling dermatitis.
LMS was the first p63 syndrome linked to chromosome region 3q27. 
Mutations in LMS are located in the N- and C-terminus of the p63 gene. LMS 
phenotype comprises malformations of the hands and/or feet and hypoplastic 
nipples and/or mammary glands. Ectodermal defects are much less prominent 
than in EEC syndrome but mammary gland hypoplasia or aplasia is more 
frequent in LMS than in EEC. 
ADULT syndrome phenotype is most similar to LMS syndrome, although 
clear differences can be seen when observing larger families or patient 
population. The main difference is the absence of orofacial clefting and the 
presence of hair and skin defects in the ADULT syndrome. Neverthless, teeth, 
skin, nail, hair and lacrimal duct defects are constantly present in ADULT 
syndrome (100, 91, 100%, 53% and 67%, respectively). A point mutation in 
exon 8, changing R298 in the DNA binding domain into either a glutamine or a 
glycine has been found. While EEC syndrome mutations in the DNA binding 
domain impair the binding of p63 protein to DNA (Celli et al, 1999), arginine 
298 is not located close to the DNA-binding interface, and mutation of this 
arginine does not affect DNA binding (Duijf et al, 2002). Two other mutations 
are located in the N-terminus.
RHS was first described in 1968 by Rapp and Hodgkin in three individuals 
from one family with sparse eyebrows, slow-growing wiry scalp hair, nail 
dystrophy, hypodontia, clefting, hipohidrosis, and a characteristic facies. RHS
share most features with AEC, but is differentially classified because of the 
lack of skin erosions and the absence of ankyloblepharon. Other ED symptoms, 
such as orofacial clefting and the absence of limb malformations are similar to 
AEC. In both syndromes clefting in lip and/or palate is equally frequent. The 
strong overlap between AEC and RHS suggest that they are variable 
manifestations of the same clinical entity (Bertola et al, 2004; Rinne et al, 
2007). AEC and RHS mutations are located in the C-terminus of the p63 
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protein. They are either point mutations in the SAM domain or deletions in the 
SAM or PS domains (Barrow et al, 2002; Celli et al, 1999; Kantaputra et al, 
2003; McGrath et al, 2001; van Bokhoven & Brunner, 2002). In 2001, 
heterozygous missense mutations in the TP63 gene were identified as the 
molecular basis for AEC syndrome and, in 2003, the first TP63 gene mutation 
was reported in RHS.
SHFM is a pure limb malformation (ectrodactyly and syndactyly) condition, 
without orofacial clefting or ectodermal dysplasia. The non-syndromic SHFM4
is caused by several mutations, which are dispersed throughout the p63 gene 
and probably it is caused by altered protein degradation, even though different 
degradation routes are involved (Rinne et al, 2007). A non-syndromic orofacial 
clefting type was also linked to p63 gene, R313G is the first mutation 
discovered (Leoyklang et al, 2006).
Figure 5. Various combinations of ectodermal dysplasia, orofacial clefting 
and limb malformations are the hallmark of p63-associated syndromes. 
EEC syndrome is the prototype of these syndromes and together with LMS 
shows all three hallmarks. ADULT syndrome patients never show orofacial 
clefting, whereas AEC and RHS never show limb defects. Non-syndromic limb 
defect condition (SHFM4) and non-syndromic cleft lip/palate (NSCL) are also 
caused by mutations in the p63 gene. (From Hans van Bokhoven et al, 2007)
1.5 AEC syndrome
Ankyloblepharon-Ectodermal defects Cleft lip/palate syndrome (AEC), also 
known as Hay–Wells syndrome, was first reported by Hay and Wells in 1976
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(Hay & Wells, 1976). It is a rare autosomal dominant disorder, characterized 
by congenital fusion of the eyelids (ankyloblepharon), ectodermal dysplasia 
with severe involvement of the skin, and cleft palate with or without cleft lip. 
Clinical manifestations have different penetrance: about 75% of patients have 
severe skin erosions at birth, with some AEC patients reported to have up to 
70% denuded skin. By 4 – 5 years age erosions could disappear, except for the 
head and auricular region. Clefting occurs approximately in 80% of AEC 
patients. The ankyloblepharon occurs only in 44% of AEC cases (Fig. 6).
Hearing loss has been reported in about 40% of the patients. AEC patients have 
nails and teeth defects in about 75–80% of cases (Fig. 6). About half of the 
patients have lacrimal duct atresia. Dermatological features include thin and 
dry skin, often associated with congenital erythroderma, widespread skin 
erosions at or soon after birth, and erosive keratoderma of palms, soles and thin
hair and/or alopecia. The most severe cutaneous manifestation of this disorder 
is the skin fragility associated with severe skin erosions after birth. Erosions 
typically involve the scalp, head and neck, skin folds, palms, and/or soles and 
are often accompanied by crusting and secondary infections (Fig. 6). Skin 
lesions are a distinctive signs of AEC syndrome. Adult patients can be affected 
by palmoplantar hyperkeratosis and erosive palmoplantar keratoderma with 
bleeding after extensive walking. The biological mechanisms underlying the 
skin erosions remain unveiled, and treatment is limited to gentle wound care 
and antibiotic treatment to prevent or cure infections. Healing is slow and 
recurrent breakdown is typical. 
In AEC syndrome pathogenic mutations mainly fall in the C-terminus of p63 
protein and include twenty-five missense and only two frameshift mutations in 
the SAM domain, whereas in the PS domain predominate the frameshift 
mutations that extend p63 protein (Rinne et al, 2009). These mutations give 
rise to mutant p63α proteins with dominant effects towards their wild-type
counterparts. Recently, novel AEC causative mutations have been identified 
that result in translation re-initiation downstream of the non-canonical
transactivation domain in the ΔN-specific isoforms, leading to expression of 
truncated ΔNp63 protein with dominant negative effects (Rinne et al, 2008).
AEC syndrome differs from the other conditions by the severity of the skin 
phenotype, the occurrence of ankyloblepharon, and the absence or mild limb 
malformations.
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Figure 6. Clinical appearance of a child affected by AEC syndrome. a) A 
close up of reticulated scarring that is typically seen in AEC patients as the 
results of skin erosions healing processes. b) Scalp erosions with hemorrhagic 
crusting, granulation tissue and secondary infection. c) Dystrophic fingernails 
of AEC patients, characterized by small nails with partial loss/absence and 
distal fraying of the nail plate. d) Focal fusion of the eyelids (ankyloblepharon) 
(Adapted from Ferone et al., 2015).
1.6 AEC mouse models
To study the functional activity of mutant p63 in AEC syndrome a first 
knock-in mouse model (p63+/L514F) was generated in our laboratory (Ferone et 
al, 2012).
This model carries a phenylalanine substitution in position 514 (L514F) and 
closely resembles the human disease (Ferone et al, 2012). This mutation falls 
in the first helix of the SAM domain and disrupts the folding of the protein. 
Among the AEC causative mutations we decided to focus our attention on 
L514 amino acids for three reasons: first of all, this amino acid is mutated in 
three different amino acids (phenylalanine, valine or serine); this mutation 
affects an amino acid that is predicted to be buried inside the protein and has a 
small solvent accessible surface, so any mutation in this region is likely to 
affect the overall structure and stability of the protein by altering the packing of 
the helices, and moreover the substitution of a leucine with a phenylalanine 
probably cause a severe steric clash between two phenylalanine rings that are 
located close to each other (McGrath et al, 2001; Rinne et al, 2007).
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p63+/L514F mouse model is characterized by hypoplastic and fragile skin, 
ectodermal dysplasia and cleft palate (Fig. 7). Ferone et al., 2012, found that 
epidermal hypoplasia and cleft palate are associated with a transient reduction 
in epithelial cell proliferation during development. These defects closely 
resemble those observed in the Fgfr2b-/- mice (Candi et al, 2006; De 
Moerlooze et al, 2000; Petiot et al, 2003; Rice et al, 2004; van Bokhoven et al, 
2001). Since p63 transcriptionally controls the Fibroblast growth factor 
receptors Fgfr2 and Fgfr3 and their expression, they found that impaired FGF 
signaling downstream of p63 is likely an important determinant of reduced 
ectodermal cell proliferation and defective self-renewing compartment in AEC 
syndrome. Unfortunately, a neonatal lethality due to cleft palate prevented the 
generation of a mouse line and the studying of the adult phenotype. 
Figure 7. Child affected by AEC syndrome compared to the constitutive
AEC mouse model. Comparison between AEC syndrome phenotype and 
constitutive AEC mouse model indicated that the mouse model faithfully 
recapitulated some human features, as cleft palate, skin erosions and dental 
abnormalities.
1.7 Skin immune function 
The function of the skin as a physical and biochemical barrier is due by 
terminally differentiated epidermal keratinocytes (KCs) and by the acidic, 
hydrolipidic nature of the skin, as a result of sweat, sebum, lipids, and 
antimicrobial peptides (AMPs). 
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In the epidermis are present also melanocytes and immune cells such as 
Langerhans cells (LCs) and T lymphocytes. By the other hand, the dermis is 
composed of a stratum papillare and a stratum reticulare containing thin and 
thick collagen fibers, respectively. The collagen fibers offer a mechanical 
barrier as well as a structural framework in which to host blood vessels and 
many immune cells such as dermal dendritic cells (DDCs), αβ T cells, γδ T
cells, natural killer (NK) cells, B cells, mast cells, and macrophages. Moreover 
mice, but not humans, possess Vγ5Vδ1 T cells, named dendritic epidermal T 
cells (DETCs) for their morphology and location. DETCs constitute more than 
90% of epidermal T cells, forming an interdigitating network with 
keratinocytes and LCs (Di Meglio et al, 2011) (Fig 8).
Figure 8. Skin cellular effectors involved in inflammation response. The
skin covers an active role in the immune system. The epidermis is responsible 
for the maintenance of epithelial barrier integrity. It is also populated by 
melanocytes, which produce pigment (melanin), Langerhans cells and CD8+ T 
cells in the basal layer and in stratum spinosum. The dermis is constituted of 
collagen, elastic tissue and reticular fibers. It is populated by specialized cells, 
such as dendritic cells (DCs) and T cells, but also by macrophages, mast cells,
and fibroblasts (Adapted from Nestle et al, 2009).
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The skin contains two distinct T cells populations: a population of epidermis-
resident memory CD8+ T cells, also known as cytotoxic T cells and a 
population of recirculating memory CD4+ T cells, recognized as T helper cells 
(TH). Once infection has resolved and immunological memory has taken place, 
memory CD8+ T cells remain sequestered in the epidermis, close to the 
original infection site. In contrast, memory CD4+ T cells rapidly circulate 
through the dermis, re-enter the circulation, and rapidly reach previously 
uninvolved skin in the case of secondary infection (Gebhardt et al, 2011).
Upon the activation by immunogenic peptides presented by antigen-presenting
cells (APC), naive TH lymphocytes can differentiate into two TH cell 
populations, TH1 and TH2. TH1 cells typically produce interleukin-2 (IL-2)
and interferon-γ (IFN-γ), induce macrophage activation, and are very ejective 
in controlling infection with intracellular pathogens. By contrast, TH2 cells 
secrete IL-4, IL-5, and IL-13 and they are excellent helpers for B cells in the 
antibodies production, and they are required to eradicate helminths and 
extracellular parasites.
In addition to these cytokines, IL-20, a member of IL?10?related cytokines 
also involved in TH2 inflammatory response, is released properly by 
keratinocytes. In particular, it is an autocrine signal that leads to keratinocyte 
proliferation, epidermal thickening, and it is associated with inflammatory skin 
diseases such as psoriasis and atopic dermatitis. Engagement of the IL-20
receptor activates STAT3 and promotes wound healing, epithelial proliferation 
and elaboration of antimicrobial peptides (Gebhardt et al, 2009).
Keratinocytes can be considered the first immune sentinels encountered by 
pathogens and are therefore, quick and efficient in sensing and responding to
danger (Nestle et al, 2009). On first encountering a microbe, KCs are alerted to 
potential danger by recognizing conserved microbial structures known as
pathogen-associated molecular patterns (PAMPs) via their pattern recognition 
receptors (PRRs) (Takeuchi & Akira, 2010) such as Toll-like receptors (TLRs), 
which keratinocytes express on their surface (TLR-1, TLR-2, TLR-4, TLR-5,
and TLR-6) and in their endosomes (TLR-3 and TLR-9). TLR engagement 
triggers activation of nuclear factor- kappa B (NF-kB) and interferon 
regulatory factor (IRF), which in turn induces immune and inflammatory 
genes, namely, tumor necrosis factor (TNF) and type I IFNs (Di Meglio et al, 
2011).
Another way in which KCs try to limit the immediate microbial threat is by 
releasing pro-inflammatory cytokines activating “the inflammasome”, a 
multiprotein complex (Feldmeyer et al, 2010). This in turn activates the 
enzyme caspase 1, which cleaves unprocessed pro-interleukin-1b (pro-IL-1b)
and pro-IL-18, stored in KCs, into the active IL-1b and IL-18. Activated 
keratinocytes release processed IL-1 (Dombrowski et al, 2011), enabling 
neighboring epithelial cells to respond by amplifying the signal through further 
production of IL-1a, in addition to IL-1b, TNF, and IL-6.
Another critical role covered by KCs in the defense against invading 
microorganisms is the induction of AMPs. There are many cationic AMPs, 
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such as the cathelicidin, defensins, and S100 family proteins (Harder & 
Schroder, 2005). These cationic molecules destroy bacteria by creating holes in 
their anionically charged cell walls or by sequestrating iron required for 
bacterial growth (Glaser et al, 2005). Pro inflammatory cytokines (IL-1a, IL-
1b, IFN-g, TNF) differentially regulate the expression of genes encoding for 
several AMPs, and IL-17A, IL-17F, and IL-22 are potent inducers of AMPs 
(Sonnenberg et al, 2011).
In response to most type-2-cell-mediated stimuli, barrier epithelial cells (ECs) 
produce cytokines such as IL-33, thymic stromal lymphopoietin (TSLP), and 
IL-25 that activate DCs to promote adaptive Th2 cell immunity, and license the 
innate type 2 cell response by activation of ILC2s, basophils, eosinophils, and 
mast cells (Allakhverdi et al, 2007) (Fallon et al, 2006) (Halim et al, 2012)
(Schmitz et al, 2005). These cytokines represent an innate ‘‘pro-Th2’’ cell set 
of cytokines. 
In addition to the polarizing cytokines IL-25, IL-33, and TSLP, ECs can 
regulate type-2-cell-mediated immunity through the production of endogenous 
danger-associated molecular patterns (DAMPs) or alarmins (Hammad & 
Lambrecht, 2015). The alarmins high mobility group box 1 (HMGB1), S100 
family proteins, IL-33, and IL-1a are normally localized in the nucleus. 
However, they can be released by non-programmed cell death or be actively 
secreted in a process not requiring the classical cellular secretion pathway 
involving vesicular transport from the Golgi complex. It would be interesting 
to further investigate the role of these alarmins in skin diseases and also in 
homeostatic conditions. 
Other important actors of barrier type 2 immunity are granulocyte macrophage 
colony stimulating factor (GM-CSF), known in mouse as Colony stimulating 
factor 2 (Csf2), and granulocyte colony stimulating factor (G-CSF), called in 
mouse as Colony stimulating factor 3 (Csf3). These growth factors are released 
by ECs and stimulate the proliferation, maturation, and function of antigen-
presenting cells (APCs) like DCs and macrophages, and also promote 
eosinophil survival (Figure 9).
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Figure 9. Skin-resident immune sentinels. Any type of barrier disruption
such as ultraviolet (UV) light damage, trauma, skin infections or irritants 
triggers a coordinated immune response to maintain skin homeostasis. Skin-
immune cellular components are considered key sentinels for restoring 
homeostatsis but can also be effector cells under skin inflammation conditions.
Langherans cells, which also belong to the family of DCs, are key 
immunological sentinels. Keratinocytes sense and react to dangerous stimuli by 
producing pro-inflammatory cytokines (such as IL-1b, IL-6, IL-18 and TNF), 
which activate DCs. Dermal dendritic cells activate and promote the expansion 
of skin-resident memory CD4+ or CD8+ T cells. T cells produce pro-
inflammatory cytokines and chemokines, thus amplifying the inflammatory 
reaction. Furthermore, skin-resident T cells can migrate into the epidermis, 
engaging in an immune-epithelial crosstalk (Adapted from Nestle et al, 2009).
1.8 Thymic stromal lymphopoietin (Tslp), one of the most important 
alarmins in skin inflammation
Thymic stromal lymphopoietin (TSLP) belongs to the interleukin (IL)-2
cytokine family, specifically it is a paralog of IL-7 (Leonard, 2002) (Friend et 
al, 1994). TSLP is involved in several immunoregulatory functions, but in 
particular it is able to stimulate thymocytes to induce the production of TH 
lymphocytes and the consequently differentiation of TH2 cells and the relative 
production of IL4 and IL13. TSLP, as IL-7, promotes the differentiation of B-
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cells and it is also able to evoke itch in atopic dermatitis patients (Wilson et al, 
2013). It is also implicated in the pathogenesis of asthma, as the agent 
sensitizing the lung to allergens (Demehri et al, 2009a).
Human and murine TSLP are very similar, in fact they share a high degree of 
homology (Reche et al, 2001) (Sims et al, 2000). During allergic inflammation, 
the primary producers of TSLP are epithelial cells, such as keratinocytes, and
stromal cells although recent data have demonstrated that both dendritic cells 
(DCs) and mast cells are capable of TSLP production (Soumelis et al, 2002)
(Watanabe et al, 2004) (Ying et al, 2005) (Kashyap et al, 2011) (Moon et al, 
2011).
Several kind of cells, such as T cells, B cells, natural killer (NK) cells, 
monocytes, basophils, eosinophils and DCs, and non hematopoietic cell 
lineages such as epithelial cells respond to the TSLP regulation and express the 
Tslp Receptor (TSLPR) (Fig 10). TSLPR is constituted by two units: the 
former, the TSLPR subunit and the latter, the IL-7Rα chain both in humans and 
mice (Ziegler & Artis, 2010) (Reardon et al, 2011).
Figure 10. Tslp’s cellular targets. Tslp acts on several cellular targets such as 
lymphocytes (B and T-cells), granulocytes, DCs, natural killer T cells (NKT), 
mast cells, eosinophils, and basophils.
The early studies characterizing TSLP showed that TSLP could support B-cell
development (Friend et al, 1994) (Levin et al, 1999). Several groups 
demonstrated the association of TSLPR mutations with a subtype of B cell 
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leukemia confirming that altered TSLP expression can have a significant 
impact on B cells (Chapiro et al, 2010) (Roll & Reuther, 2010) (Tasian & Loh, 
2011). In addition, elevated systemic levels of TSLP has been demonstrated to
lead to aberrant B-cell lymphopoiesis, with direct actions on B cell 
development and indirect effects leading to autoimmune diseases (Astrakhan et 
al, 2007) (Iseki et al, 2012). Indeed, Demehri et al proved that in Notch1;
Notch2 conditional knock out mice high systemic levels of Tslp caused the 
insurgence of a B-lymphoproliferative disorder, an autoimmune condition
associated to Tslp (Demehri et al, 2008).
1.9 Signaling pathway involved in Tslp regulation
Nowadays, the mechanism of action of Tslp has not yet been defined. Several
research groups are still working in this field. So far, Murthy et al have
demonstrated that ADAM17 is involved in the basal Notch activation and it
triggers Notch signaling to regulate c-Fos activation, monitoring so epidermal
barrier homeostasis. Loss of this control induces the production of cytokines or 
alarmins, such as Tslp and IL33, which trigger immune responses. Independent
studies have demonstrated that the loss of Notch, deregulation of AP-1
signaling pathway, or elevated production of epithelial TSLP results in
inflammatory skin disease (Demehri et al, 2009a) (Dumortier et al, 2010).
Moreover, Wilson et al showed a new role covered by TSLP. They 
demonstrated that it might evoke itch behaviors directly by activating sensory 
neurons, and indirectly by activating immune cells, which secrete
inflammatory mediators that target sensory neurons, or both. Indeed, 
keratinocytes may directly communicate with sensory neurons via 
neuromodulators (Ikoma et al, 2006). The release of TSLP by keratinocytes has 
been demonstrated that is correlated to the GPCR protease-activated receptor 2 
(PAR2) and to Ca2+ influx that activates the NFAT/calcineurin pathway which 
triggers the activation of Tslp transcription (Wilson et al, 2013). TSLP
secretion has been demonstrated be calcium dependent. Epithelial cells such as 
keratinocytes express Ca2+ channel on their surface like ORAI1, ORAI2. In 
keratinocytes, the ORAI1 signaling pathway connects PAR2 to TSLP release. 
The activation of PAR2 allows the release of Ca2+ from endoplasmic reticulum 
and the activation of ORAI1 regulator, called STIM1 (STromal Interaction 
Molecule 1) that opens ORAI1 channels to promote Ca2+ influx. Ca2+ activates
calcineurin, a phosphatase involved in the NFAT dephosphorylation. NFAT 
dephosphorylated translocates from the cytoplasm to the nucleus and induces 
the transcription of TSLP. Wilson and colleagues found that TSLP is released 
by keratinocytes under Ca2+ influx and it activates sensory neurons directly to 
evoke itch behaviors. In addition, they identify the ORAI1/NFAT signaling 
pathway as a key regulator of PAR2-mediated TSLP secretion by epithelial 
cells. Instead, Furio et al (Furio et al, 2015) showed that patients affected by 
Netherton syndrome (NS) presented elevated systemic levels of Tslp. They
demonstrated that the overproduction of Tslp in NS syndrome is related to the 
? ????
activation of PAR2-NF-κB axis by kallikrein 5 (KLK5) activity. NS is a 
disorder characterized by severe skin inflammation, scaling and atopy for
which physicians and scientists do not have a complete understanding. In NS 
patients, an intrinsic mechanism takes place in keratinocytes and leads to 
increased expression of TSLP, TNF-α, IL-8 and ICAM-1 as a result of PAR2 
activation by active KLK5. Overall, the mechanisms underlying Tslp action are 
tricky and involve several pathways. It will take some time for scientists to
understand the pawn genes involved in this mechanism.
1.10 Kallikrein proteases involved in the activation of PAR2 receptor
Kallikreins (KLKs) or kallikrein related peptidases are a subgroup of 
extracellular serine proteases. They have been divided in two major categories:
the former corresponds to plasma KLK (only KLK1B belongs to this 
category), the latter corresponds to the tissue KLK family (KLK1-KLK15)
(Prassas et al, 2015).
KLK1B, the only example of plasma KLKs, is produced in liver and it has a 
conformation and a structure completely different from tissue kallikreins. 
Tissue KLKs in turn can be divided in two different families, the chemotrypsin
and the trypsin-like serine proteases. 
KLKs are synthesized as inactive zymogens, pre-pro-KLK proteins, which are 
then autoactivated or activated by different KLKs or by other proteases. The 
activation of pro-KLK zymogens happens extracellulary thanks to the trypsin-
like cleavage of the pro-peptide and it is a key mechanism in regulating KLK 
activity in tissues. Once activated, KLKs play their role of serine proteases in 
catalytic mechanism.
Tissue KLKs can acts by their selves or they are involved in tissue-specific
proteolytic cascades. Altered expression of KLKs activity is correlated to 
different-specific pathologies. 
In the epidermis are present both trypsin- and chemotrypsin-like serine 
protease, about nine KLKs, such as KLK1, KLK5-KLK8, KLK10, KLK11, 
KLK13 and KLK14, are co-expressed in the stratum corneum and upper 
stratum granulosum of normal human epidermis. In normal condition, pro-
KLKs are required and activated to maintain skin-barrier integrity. They are 
involved in three main functions: 1) promotion of skin desquamation and/or 
keratynocites proliferation, regulating skin renewal and barrier thickness; 2) 
regulation of lipid metabolism by controlling lipid-processing enzymes and the 
activation of PAR2; 3) processing of pro-cytokines and antimicrobial peptides 
involved in innate immune responses.
The activity of KLKs family in epidermis is played by KLK5, also known as 
stratum corneum tryptic enzyme (SCTE), KLK7, also called as stratum 
corneum chymotryptic enzyme (SCCE), KLK8, and KLK14. These KLKs are
secreted by keratynocytes into stratum corneum and after secretion they 
participate in a proteolytic cascade. KLK5 is able to auto-activate and to
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initiate the proteolytic cascade. It subsequently activates pro-KLK7, pro-KLK8
and pro-KLK14 by cleaving their pro-peptides (Fig. 11). After the activation, 
KLK5 and KLK7 cleave corneodesmosomes, which are composed by DSG1, 
DSC1 and corneodesmosin, let’s starting the skin desquamation process or 
shedding of SC corneocyte cells. Matriptase, an activator of serine-protease
and the lympho-epithelial Kazal type inhibitor (LEKTI), which is a protease 
inhibitor, regulate KLK activity both in normal and pathologic condition. 
KLK5, KLK6 and KLK14 are able to activate the keratinocyte-expressed
proteinase-activated receptor 2 (PAR2), beginning an inflammation process
mediated by NFAT/calcineurin/Tslp signaling pathway (Wilson et al, 2013).
Figure 11. The proteolytic cascade of kallikreins in skin epidermis. KLKs
in the epidermis are secreted by lamellar granules (LG) of keratinocytes in the 
stratum granulosum into the stratum corneum (SC). Upon secretion it starts
their activation and the related proteolytic cascade (Adapted from Prassas et al, 
2015).
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2. AIM OF THE STUDY 
The aim of my project was to study the conditional AEC mouse model in 
post-natal life and to understand the molecular mechanism underlying the AEC 
syndrome. In particular, my study focused on the characterization of the
inflammatory state associated with the severe phenotype of AEC conditional 
mice and the generation and characterization of a novel conditional model for 
AEC syndrome in a Tslp null background. Tslp is an alarmin, involved in the 
insurgence of the inflammatory state and it plays an important role in AEC 
syndrome. For this reason, we decided to generate an AEC mouse model in a 
Tslp null background to understand what happens in AEC conditional mice in 
the absence of this particular cytokine. 
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3. MATERIALS AND METHODS
3.1 Generation of conditional p63+/FloxL514F mouse model 
We recently generated a conditional knock-in model (p63+/FloxL514F), in which 
the L514F mutation is expressed only in the presence of the CRE recombinase.
The knock-in/replacement strategy was designed to replace the wild-type
amino acid Leucine (Leu, L) encoded by codon 514 with a sequence coding for 
Phenylalanine (Phe, F) in the p63 protein in murine embryonic stem (ES) cells 
by homologous recombination.  The targeting construct contained two LoxP 
flanking fused wild-type exons 13 and 14 placed upstream a neomycin 
resistance cassette flanked by FRT loci and a mutant exon 13 followed by the 
exon 14 and an immune epitope tag (3xFlag) at the end of this.
3.2 Mouse genotyping
Conditional knock-in p63+/FloxL514F, p63FloxL514F/FloxL514F, K14Cre;p63+/FloxL514F
(+/L) and K14Cre;p63FloxL514F/FloxL514F (L514F) were genotyped by PCR using 
genomic DNA isolated from mouse tails.
Oligonucleotide primers used for PCR:
Conditional knock-in p63+/FloxL514F, p63FloxL514F/FloxL514F





The expected bands were of 250bp for the wild-type mice, 337bp for the 
mutant homozygous mice and both for the heterozygous ones.
To distinguish the presence of K14-Cre recombinase in p63 heterozygous and 
homozygous mice we used the following primers for PCR:





L514F; Tslp eKO mice were obtained by crossing K14-Cre; p63+/FloxL514F with
Tslp FloxL2/FloxL2 received from Pierre Chambon (Li et al, 2009).
Primers used to genotype Tslp line: 





The expected bands corresponded to 333bp for the wild-type mice, 450bp for 
the mutant homozygous mice and both for the heterozygous ones.
3.3 Western blot 
For immunoblotting cells were lysed in sample buffer (10% glycerol, 0.01 % 
Bromophenol Blue, 0.0625 M Tris-HCl pH 6.8, 3 % SDS, 5 % ß-
mercaptoethanol) supplemented with protease inhibitors. For immunoblotting 
of epidermal extracts, epidermis was isolated from dermis by producing a 
thermal shock at 55°C or by floating skin biopsies, epidermis side up in a
dispase solution. After isolation from dermis, epidermis was snapped frozen in 
liquid nitrogen and then homogenized with a tissuelyser in lysis buffer 
supplemented with phosphatase and protease inhibitors. Proteins were run on a 
denaturing SDS-PAGE gel and subsequently transferred to Immobilon-P
transfer membranes (Millipore) probed with primary antibodies and detected 
by chemiluminescence (ECL, GE Healthcare Life Sciences). Antibodies used 
for immunoblotting were: p63 (4A4 Santa Cruz Biotechnology), Cdh1 (BD
Bioscience), Krt5, Krt14, Krt1, Krt10, Ivl, Lor (all Covance), Krt15 (a gift 
from doct. Langbein), β-actin (Santa Cruz Biotechnology), Klk5 and Klk7 
(RD Systems), Klk6 (a gift from doct. Mari Kishibe).
3.4 Real-time RT-PCR
Mouse epidermis was isolated from dermis by digestion with dispase
solution. Total RNA was extracted from primary keratinocytes or epidermis 
using TRIzol reagent (Invitrogen). cDNA was synthesized using SuperScript 
Vilo (Invitrogen). Two-step real-time reverse transcription RT-PCR was 
performed using the SYBR Green PCR master mix in an ABI PRISM 7500 
(Applied Biosystems). Levels of the target genes were quantified using specific 
oligonucleotide primers and normalized for Actin (ß-actin) or RPLP0 
expression.
Oligonucletide primers used for Real-Time RT-PCR on mouse samples:














































































































Oligonucleotide primers for Real Time RT-PCR on human samples












3.5 Primary keratinocytes and cell cultures
Newborn mice were placed in petri dishes with ice and inserted in an ice 
bucket. After 30-45’ newborn mice were washed twice with 70% ethanol and
twice with water to remove ethanol completely. Using sterile techniques, mice 
tails and limbs were amputated with sterile surgical scissors. Single skin was 
carefully separated from the rest of the viscera and flattened in a empty 6 well
dish with the dermis facing down; 2 ml of Dispase solution (0.5mg Dispase-
GIBCO, Na-bicarbonate 0.75%, Hepes 10mM, Antibiotic-Antimycotic in PBS) 
were added to each 6 well dish and incubated o/n at 4 °C. Next day epidermis
was separated from the dermis and placed in a 100mm Petri dish in 2ml (for 
each epidermis) of 0.125% trypsin- 0.1mM EDTA. Epidermis was minced with
tweezers and scissors until was reduced in very small fragments and placed at 
37°C for 5-8 minutes. Then trypsin was inactivated with DMEM+10% FBS 
and filtered by applying it to cell strainer in order to remove the floating 
particles. Cells were placed into the centrifuge for 5 minutes at 1000 rpm; then 
were plated on collagen coated plates (1.2x106 cells/ml) and incubated at 
34°C, 8% CO2. Primary mouse keratinocytes were isolated from newborn 
mice and cultured under low calcium conditions (0.05 mM) or treated with 
2mM calcium chloride as previously described (Antonini et al, 2010).
Human keratinocytes obtained from AEC patients Q11X and T533P (kindly 
provided by J. Zhou, (Ferone et al, 2013)), as well as control keratinocytes 
obtained by unaffected individuals were plated at a density of 104cells/cm2 and
cultured in KBM Gold medium (Lonza) till they reach confluency. Confluent 
cells were treated with 0.3mM calcium for subsequent RNA analysis. 
Knockdown was achieved by transient transfection of 100nM small
interfering RNA (siRNA) for pan-p63, ∆Np63 (De Rosa et al, 2009), or
negative control (Invitrogen).
3.6 Retroviral infection 
Mouse primary keratinocytes were infected the day after plated with 
retroviruses carrying the GFP (GINCO), NFATc1 (Porter & Clipstone, 2002)
for 2 hours. After the infection cells were washed with PBS and were cultured 
in LCM4% for a week at 34°C.
3.7 Gene expression microarrays
We measured the differential expression of 22000 RNA on freshly isolated 
epidermis from three mutants versus three wild-type newborn mice. We 
hybridized the RNA samples to the Affymetrix Mouse Genome 430A 2.0 
chips. We processed the microarrays using the RMA algorithm. False 
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Discovery Rate (FDR) correction was performed on the estimated p-value to 
correct for multiple hypothesis test.
3.8 Histology and Immunostaining 
Dorsal skin was dissected, fixed in 4% paraformaldehyde (PFA) and 
embedded in paraffin or in OCT, from which 7 μm sections were cut and 
stained with Haematoxylin and Eosin (H&E), Toluidine blue and
immunofluorescence according to standard methods. For paraffin sections, 
permeabilization for antigen retrieval was performed by microwaving samples 
in 0.01 M citrate buffer at pH 6.0. The following antibodies were used: keratin
6, keratin 5, keratin 14 (Convance), p63 (4A4, Santa Cruz Biotechnology),
Ecadherin (Zymed laboratories-Invitrogen), guinea pig antibody to keratin 15 
(a gift from Doctor Langbein), FLAG M2 (Sigma), anti-TSLP antibody (RD
Systems), anti-F4/80 (Abcam), anti-CD45 (eBioscience), anti-HMGB1 (a gift 
from Doctor Marco Bianchi), anti-Ki67 (Dako), NFATc1 (clone 7A6 Santa 
Cruz Biotechnology), Klk6 (a gift from doct. Mari Kishibe).
The following secondary antibodies were used for immunofluorescence 
staining: Alexa Fluor ® 488 goat anti-mouse (Invitrogen), Alexa Fluor ® 594 
goat anti-rabbit (Invitrogen), Alexa Fluor ® 594 goat anti-rat (Invitrogen). 
Fluorescent signals were monitored under a Zeiss Axioskop2 plus image 
microscope or under a Zeiss confocal microscope LSM510meta. Sections were 
counterstained with DAPI nuclear stain.
3.9 ELISA
Serum TSLP levels were determined using Quantikine mouse TSLP kit 
according to manufacturer’s instructions (RD Systems). Serum IgE levels 
were measured using Mouse IgE ELISA kit (Immunology Consultants 
Laboratory).
3.10 FACS Analysis
Single cell suspension from Bone Marrow (BM) and spleen were prepared 
for Flow cytometry (FC) analysis transferring the freshly dissected lymphoid 
organ to a 60 x 15-mm culture dish containing 4 ml of HBSS supplemented
with 5% serum. Then the spleen was placed between the frosted ends of two 
glass microscope slides. The organ was disrupted by gently pressing the frosted 
ends in a circular motion until only the empty capsule remains. Instead, bone 
marrow was simply syringed. The resulting cell suspension were transferred to 
a 15-ml conical centrifuge tube and was resuspended with a combined total of 
3 ml of 5% HBSS. The cell suspensions were centrifuged for 10 min at 200 x 
g, 4 C, then the supernatant was discarded and the pellet resuspended in 
HBSS and labeled with the specific antibodies. The following antibodies were 
used: anti-B220/CD45R (RA3-6B2) conjugated to PE-Cy7, anti-CD43 (S7)
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conjugated to FITC both from BD Pharmingen, anti-IgM conjugated to FITC 
(RMM-1) from Biolegend. Stained cells were studied using a BD FACS 
CANTO II, and the data were analyzed using FACS DIVA software. 
3.11 Skin Barrier Assays
To perform X-gal staining, unfixed, untreated newborn mice or embryos
were washed in PBS and then incubated overnight at 37°C in 5-bromo-4-
chloro-3-indlyl-b-D-galactopyranoside (X-gal) reaction mix (100 mM NaPO4,
1.3 mM MgCl2, 3 mM K3Fe[CN]6, 3 mM K4Fe[CN]6, and 1 mg/ml X-gal
[pH 4.5]). At pH 4.5, the skin exhibits endogenous b-galactosidase activity, so 
increased X-gal staining indicates epidermal permeability to X-gal, a sign of 
compromised barrier function (Hardman et al, 1998).
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4. RESULTS 
4.1 AEC conditional mouse model is characterized by an epidermal-
specific L514F mutation that results in severe skin phenotype
To dissect the molecular defects occurring after birth in AEC syndrome and 
to overcome the lethality of the constitutive AEC mouse model (Ferone et al, 
2012), we generated a conditional knock-in p63floxL514F mouse model, in which 
the L514F mutation was expressed only in the presence of the CRE 
recombinase and it is fused to a 3xFLAG tag at the C-terminus (Fig 12A). The 
knock-in strategy was designed to replace the wild-type amino acid leucine 
encoded by codon 514 with phenylalanine in the p63 protein in murine 
embryonic stem (ES) cells by homologous recombination. To overcome the 
neonatal lethality due to cleft palate we crossed p63+/floxL514F mice with K14-
Cre knock-in mice, in which Cre is highly expressed by embryonic day 17.5
(E17.5) in the epidermis and in the hair follicle under the control of the 
endogenous keratin 14 (K14) promoter (K14-Cre ∆neo) (Huelsken et al, 2001).
Immunofluorescence analysis with anti-FLAG antibody, which specifically 
recognizes the mutant protein, revealed a nearly uniform expression of the 
mutant protein in the basal compartment of the interfollicular epidermis at
postnatal day 2(P2) (Fig. 12B).
Figure 12. Generation of K14-Cre ∆neo; p63+/floxL514F AEC mutant 
mice. A) Gene targeting strategy used to generate the K14-Cre ∆neo;
p63+/floxL514F (+/L514F) knock-in mice. The L514F mutation is indicated 
with *, the targeted locus contains two LoxP flanking wild-type exons 
13 and 14 fused together and place upstream of a neomycin resistance 
cassette flanked by FRT loci. A mutant exon 13 followed by the exon 
14 and a 3xFLAG epitope tag at the end of this is placed after the LoxP.
Flag-tagged p63 gene is expressed upon Cre mediated deletion. B)
H&E staining of dorsal skin of K14Cre; p63+/floxL514F (+/L514F) and 
control (+/+) mice at post-natal day 2 (P2) reveals hypoplasia (upper 
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panel). Immunofluorescence analysis of Flag and Krt14 on dorsal skin 
of +/L514F and +/+ mice at P2 reveals the proper expression of mutant 
p63 protein in the basal layers of the epidermis and confirms the 
hypoplasia (lower panel). 
K14-Cre; p63+/floxL514F (+/L) newborn mice appeared normal at birth and 
exhibited in time a relatively mild but reproducible phenotype with partial and 
progressive hair loss (Fig. 13A). In adult mice (P50) histological analysis of 
the skin revealed epidermal abnormalities characterized by an overall reduction
of epidermal thickness (Fig. 13B). Similarly to what observed in the 
constitutive AEC mouse model strong reduction of Krt15 in both hair follicles 
and interfollicular epidermis was observed (Ferone et al, 2012) (Fig. 13B).
?
Figure 13. Characterization of +/L514F mouse model. A)
Photographs were taken of +/L and L/L at 30 days. B) H&E staining of 
dorsal skin of +/L514F and +/+ mice at P50 revealed hyper-cellularized
dermis and decreased fat layer in mutant skin (upper panel). 
Immunofluorescence analysis for Krt15 at P50 revealed a reduction of 
Krt15 in mutant mice compared to controls. 
Given the relatively mild phenotype, heterozygous mutant mice were crossed 
to homozigosity to obtain K14-Cre ∆neo; p63 floxL514F /floxL514F mice (from here 
on referred as L514F mutant mice), in which wild-type p63 was virtually 
absent at P3, and mutant p63 was highly expressed in homozygous mice (Fig.
14A). Immunofluorescence analysis with anti-FLAG antibody revealed a 
uniform expression of the mutant protein in the basal compartment of the 
interfollicular epidermis at birth (Fig. 14B).
A B
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Figure 14. L514F conditional expression in AEC mutant mice. A)
Real time RT-PCR for p63 wt and mutant alleles in mouse epidermis 
derived from L514F mice and controls at P3 revealed the expression of 
mutant allele in L514F mice. Data are normalized for β-actin mRNA
levels and are expressed relative to controls. Error bars denote SD. B)
Immunofluorescence staining of L514F and control (WT) skin revealed
the expression of the p63L514F-3xFLAG protein in the basal layer of 
the epidermis and hair follicle at P3 in mutant skin compared to wild-
type mice. Nuclei are stained with DAPI.
AEC mutant mice were indistinguishable from their wild-type littermates at 
birth, but ~6% P2-P5 mice displayed areas of severe skin erosion with an 
otherwise apparently normal phenotype. Starting from P5-P7, all mutant mice 
developed a progressively severe phenotype, characterized by shallow skin
erosions, exfoliative erythroderma, crusting, associated with dehydration,
chronic skin inflammation, and stunted growth (Fig. 15A). Accordingly, 70%
of mutant mice died between P7 and P20, and a significant reduction in body 




Figure 15. Phenotype of AEC mutant mice: A) Photographs are 
taken from controls and L514F mice at different stages, as indicated in 
the figure. From P2 L514F mice showed a progressively strong 
phenotype characterized at P9 by shallow skin erosions, skin crusting, 
hair loss and ulcerations that worsen throughout their life, as indicated 
at P120. B) Survival curve of L514F (L/L black line), +/L514F (+/L red
line) and +/+ (blue line) mice (P-value= 3.71682E-22; n=276). C) Body
weight at P10 of L514F, +/L514F and +/+ mice, (***P-value=2.6847E-
07; n= 72).
4.2 Epidermal blistering and altered epidermal barrier characterized AEC
mice
To test the hypothesis that the progressive dehydration observed in AEC 
mutant mice may be due to at least partially impaired integrity of the epidermal 
barrier, we employed a dye exclusion assay, a technique that stains areas with 
defective skin barrier. No abnormalities were observed at E17.5 when the AEC 
mutation starts to be expressed, whereas newborn mutant mice displayed focal 
loss of epidermal barrier (Fig. 16A). Histological analysis of the back skin 
revealed a mild epidermal hypoplasia at P0 in AEC mutant mice with 
apparently normal upper layers and an intact cornified layer (data not shown).
While no obvious disruption of the epidermal barrier were observed in the 
upper layers, small and large areas of focal blistering were observed in the 
basal layer of mutant epidermis accompanied with cytolysis and to a lesser 
extent acantholysis as shown by H&E staining (Fig. 16B) and 





epidermal blistering with areas of both acantholysis and cytolysis was 
previously reported in perilesional skin of an infant affected by AEC syndrome 
subjected to mild mechanical stress (Payne et al, 2005).
Figure 16. Epidermal blistering and skin fragility in AEC mutant 
mice. A) Barrier assay at P0 on L514F and control mice (WT) revealed
the presence of focal gaps in mutant mice at P0 (***P-value=1.58596E-
09; n= 34). B) H&E staining of the skin from newborn mice revealed
blistering both between the basal lamina and the basal layer, and
between basal layer and suprabasal compartment in mutant but not in 
wild-type epidermis at birth. C) Immunofluorescence analysis for E-
cadherin (Cdh1) on newborn skin of L514F and WT mice revealed
signs of both acantholysis and cytolysis.
Mutations or the complete absence of keratin proteins in the epidermis results 
in defective intermediate filament structure, mechanical stress-induced
cytolysis and blistering (Coulombe et al, 2009). Consistent with the phenotype 
observed in AEC mutant mice, strong reduction of Krt5, Krt15 and to a lesser 
extent Krt10 expression was observed at the mRNA and protein levels in 
mutant epidermis compared to controls (Fig.  17A and B).  Importantly, a 
similar reduced Krt5 and Krt15 expression was observed also in human 
samples derived from AEC patients at the RNA and protein levels (Fig. 17D
and 17E, and (Ferone et al, 2012)). Krt14 was less abundant at the protein level 
as previously described (Fig. 17A) (Clements et al, 2012). Ultrastructural
analysis obtained by transmission electron microscopy demonstrated reduces 
keratin bundles in the basal layer of the epidermis of mutant mice compared to 
controls (Fig. 17C). In conclusion these data indicate that the skin phenotype 
observed in AEC mutant mice is due to reduced mechanical strength of the 
P0
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lower layers of the epidermis, rather than an impairment in the epidermal 
barrier.
Figure 17. Focal epidermal barrier disruption in AEC mutant mice.
A) Immunoblotting analysis for the indicated proteins in cell extracts of
mouse epidermis derived from mutant and control mice at P3. Data are 
normalized for β-actin protein expression. B) Real time RT-PCR for 
Krt5, Krt15 and Krt10 in mouse epidermis derived from L514F mice 
and controls at P3. mRNA expression of the analyzed genes were 
strongly downregulated in mutant skin as compared to controls 
(Krt5:**P-value=0.001; n=26; Krt15:* P-value=0.006; n=13; Krt10 *P-
value=0.005; n=13). Data are normalized for β-actin mRNA levels and 
are expressed relative to controls. Error bars denote SD. C)
Transmission electron microscopy (TEM) of skin samples derived from 
newborn mice, scale bar: 2um. Reduced keratin bundles in mutant 
epidermis compared to controls is showed in the lower panel, scale bar: 
500nm. D) Immunofluorescence analysis of human AEC patients and 
controls skin with antibodies against KRT5 and KRT14 reveals a
reduction of both proteins in non lesional skin of AEC patients 
compared to controls. E) Real time RT-PCR for KRT5 in human skin 




Data are normalized for RPLP0 mRNA levels and and are represented
as mean ± SD normalized mRNA levels.
4.3 Gene expression profile of AEC mouse epidermis
To obtain a global view of changes in gene expression of AEC mutant mice, 
we performed a comparison of gene expression profiling of mutant versus 
wild-type epidermis at P3 using Affymetrix gene chip. Analysis of the data 
revealed that a subset of genes, known to be p63 target genes, is downregulated
by L514F mutation. Among the p63 targets affected in mutant epidermis we
found the two fibroblast growth factor receptors Fgfr2 and Fgfr3 and Krt15
(Ferone et al, 2012), Col17a1 and Dst, two genes encoding for 
hemidesmosome junctions (Carroll et al, 2006), Ddit4 gene, also called Redd1,
a developmentally regulated transcriptional target of p63 and p53, involved in 
DNA damage (Ellisen et al, 2002), and Notch1 and Jag2, two key components 
of the Notch signaling pathway (Nguyen et al, 2006)(Fig. 18A). By contrast,
AEC mutant epidermis displayed increased focal expression of some keratins,
including Krt6 and Keratin 16 (Krt16) that were essential to maintain 
keratinocyte integrity in wounded epidermis (18B).
Interestingly, we found a strong up-regulation of inflammatory genes. In 
particular, we found an up-regulation of one hundred fold of Tslp, an IL-7-like
cytokine produced by epithelial cells, including keratinocytes that was highly 
expressed in the epidermis of atopic dermatitis and asthmatic patients (Ziegler
& Artis, 2010) (Fig. 18B). TSLP is produced by epithelial cells and it is
involved in several processes. Indeed, Tslp caused a polarization of dendritic 
cells to drive T helper (Th) 2 cytokine production, promoted T-cell
proliferation in response to T-cell receptor activation and Th2 cytokines
production, and supported B-cell expansion and differentiation. TSLP further 
amplifies Th2 cytokine production by mast cells and natural killer T cells. 
In addition to Tslp induction, our microarray data revealed us also the 
induction of antimicrobial peptides such as the DAMPs (damage-associated
molecular pattern molecules), alarmins involved in the inflammatory response
in the event of disruption of skin barrier, such as the inflammatory complex of 
calprotectin (S100a8/ S100a9 complex), and -to a lesser extent- Defb4 and
Defb6 (Fig. 18B).
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Figure 18. Gene expression analysis. A) Microarray data confirmed
that a subsets of known p63 target genes are affected in the epidermis 
of L514F mice at P3 compared to ctr mice B) Microarray data showed
that a subset of genes involved in different biological processes were 
up-regulated consistently with what we observed in AEC mutant mice.
4.4 Inflammation in AEC mouse model 
While mutant epidermis was hypoplastic at birth, few days after (P7-P12)
acanthosis and hyperkeratosis with neutrophils accumulation on the surface 
was observed accompanied by hypercellularization of the dermis (Fig. 19A).
Increased cell proliferation was observed in mutant epidermis as determined by 
Ki67 immunostaining (Fig. 19A). In addition strong up-regulation of Krt6 was 
observed in mutant mice, indicating an altered balance between proliferation
and differentiation (Fig. 19A). To determine whether hyperproliferation could 
be a consequence of an inflammatory state, skin sections were stained with 
antibodies against several immune cell markers. Immunostaining against
CD45, a pan-leukocyte marker, revealed that the total number of leukocytes 
was strongly increased in mutant mice (Fig. 19B). A massive macrophage 
accumulation in mutant dermis was revealed using the macrophage-specific
marker F4/80 antibody, and strong induction of mast cells was observed by 
toluidine blue staining (Fig. 19B). Therefore, the presence of infiltrating 
inflammatory cells in the dermis, with concomitant increase in cell 
proliferation and Krt6 up-regulation in the epidermis suggested that an 
inflammatory response may be implicated in the development of the severe 





Figure 19. Clear signs of inflammation in L514F mice. A) H&E
staining of dorsal skin of L514F mice at P8. Mutant epidermis is 
hyperplastic with infiltration of polymorphonuclear cells (neutrophils);
mutant dermis displays a dense cellularization with few hair follicles. 
Ki-67 staining in the epidermis of a mutant mouse: only few 
proliferating cell located in the basal layer are present in control skin, 
whereas in mutant skin almost all of the cells in the basal layer and 
numerous suprabasal cells are in cell division. Immunofluorescence
analysis for Krt6 in skin at P8 reveals a strong up-regulation in mutant 
epidermis respect to the control. B) Immunofluorescence analysis for 
CD45 in skin at P8 shows the presence of leukocytes in the dermis of 
mutant skin respect to the control. The number of CD45 positive cells is 
reported in the graph (right panel; ***P-value= 0.0003; n=6). 
Immunofluorescence analysis for F4/80 in skin at P8. Macrophage
infiltration in the dermis of AEC mice calculated measuring F4/80 
positive cells is reported in the column chart (right panel; *P-
value=0.01; n=7). Histological analysis of mast cells with toluidine
blue staining in skin at P8. Massive mast cell infiltration in the dermis 
of AEC mice calculated measuring toluidine blue positive cells is 
reported in the graph (right panel; ***P-value= 6.35928E-06; n=8). 
P8
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To characterize the early steps of this inflammatory state, we firstly tested 
expression of alarmin also known as Damage-Associated Molecular Patterns
(DAMPs), molecules that are upregulated and released in response to DNA 
damage in epithelial cells triggering inflammation (Hammad & Lambrecht, 
2015). At the first time when the first signs of microscopic inflammation 
became evident (P3), the high mobility group box 1 protein (HMGB1), a 
prototypic DAMP molecule that can be passively released by damaged cells 
(Lu et al, 2012) (Kikuchi et al, 2011) was localized primarily in the nucleus of 
wild-type basal and suprabasal epidermal cells.  By contrast, in basal mutant 
epidermal cells at P3 HMGB1 nuclear signal was lost, and weak cytoplasmic 
staining was detected, whereas nuclear staining was retained in the suprabasal 
layers, consistent with cell damage localized primarily in the basal layer (Fig. 
20A). Consistent with cell damage, gene expression of the antimicrobial 
peptides S100A8 and S100A9, other DAMP proteins often induced in 
epidermal inflammation, that act as amplifiers of inflammatory responses in 
several inflammatory diseases, were strongly upregulated at the RNA level in
mutant epidermis (respectively 22x and 21x) (Fig. 20B). Similarly
antimicrobial peptides (AMPs), produced in damaged epithelia, such as 
β?defensins were respectively up-regulated (Defb4 2.58x; Defb6 1.28x). We
next tested innate cytokines such as IL-25, IL-33, and thymic stromal 
lymphopoietin (Tslp) that activate dendritic cells to promote adaptive Th2 cell 
immunity, and license the innate type 2 cell response by activation of lymphoid 
cells, basophils, eosinophils, and mast cells (Hammad & Lambrecht, 2015).
While a 4x increase was observed for IL-33, no changes were observed for IL-
25 (0.98x). By contrast we observed a massive upregulation of Tslp (788x) at
the RNA level in the epidermis, confirming the microarray data. 
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Figure 20. Inflammation in AEC mouse model. A)
Immunofluorescence analysis for HMBG-1 in skin at P3 reveals a 
nuclear-cytoplasm translocation of the protein in mutant epidermis 
compared to controls. B) Real time RT-PCR for S100A8, S100A9,
DefB4 and DefB6 in mouse epidermis derived from L514F mice and 
controls at P3. mRNA expression of the analyzed genes are strongly 
up-regulated in mutant skin as compared to controls (***P-value=
1.24E-05 and 0.0001 respectively; n=10; *P-value=0.01; n=7). Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD 
normalized mRNA levels. C) Real time RT-PCR for IL25, IL33 in
mouse epidermis derived from L514F mice and controls at P3. mRNA
expression of IL33 are strongly up-regulated in mutant skin as 
compared to controls (**P-value= 5.13937E-05; n=15); by contrast, 
mRNA levels of IL25 in L514F are down-regulated (**P-value= 0.33;
n=15). Tslp mRNA levels are strongly up-regulated (788x) in mutant
epidermis compared to controls (***P-value= 0.0002; n=18). Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD 
normalized mRNA levels. 
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4.5 Tslp as the first biochemical sign of inflammation in AEC syndrome
Global gene expression profiling revealed a massive up-regulation of thymic
stromal lymphopoietin (Tslp), whose induction may be the first biochemical
sign of inflammation in fact it is considered an alarmin. qRT-PCR analysis in 
epidermis of mutant mice at P3 confirmed that Tslp mRNA expression was up-
regulated  788x fold in mutant epidermis. Tslp was also able to reach the 
bloodstream and for this purpose we evaluated its expression also in blood 
serum derived from AEC mutant and control mice. ELISA assays revealed that 
TSLP levels >3500-fold above the normal levels in sera from mutant mice at 
P10 (Fig 21A). Interestingly Tslp protein expression was specifically detected 
in the basal and -to a lesser extent- the spinous layers of mutant epidermis at P8 
(Fig 21B). Basal layer induction of Tslp indicates that was unlikely to be due to 
a canonical defect in epidermal barrier but was rather due to defects in the 
basal layer consistent with epidermal blistering and aberrant HMGB1 
cytoplasmic localization in basal keratinocytes. 
Being AEC syndrome a rare disorder with variable penetrance, extensive 
studies in patients have not been performed. Also in AEC patients in non 
lesional skin TSLP expression is doubled as compared to control individuals 
(Fig 21C).
Figure 21. Tslp levels in human patients affected by AEC syndrome 
and in AEC conditional mouse model: A) Systemic accumulation of 
Tslp protein (ng/ml) in blood serum of mutant mice at P10 measured by 
ELISA (*P-value=0.04;n=6). B) Immunofluorescence analysis for Tslp 
and Krt10 at P8 reveals a strong expression in basal and suprabasal
mutant epidermis respect to controls. C) Real time RT-PCR for TSLP in
human skin derived from AEC patients and healthy controls (*P-value=
0.01; n=7). Data are normalized for RPLP0 mRNA levels and are 
represented as mean ± SD normalized mRNA levels.
Consistent with previous reports (Yoo et al, 2005) implicating Tslp in an atopic 
dermatitis-like phenotype, we observed increased levels of CD4+ T-cells and 
of Th2 cytokines (IL-4 5.4x; IL-13 18.7x, IL-20 26.3x, IL33 2x, IL1F5 1.6x, 
Csf2 3.8x, Csf3 1.3x), Th1 cytokines (Cxcl5 14x, IL1b 3.7x, IFNγ 5.3x, IL1F6 





(DefB1 1.4x, DefB3 574x, DefB4 300x, s100a8 100x, s100a9 106x) in skin at 
P8 (Fig. 22A), and we found elevated serum IgE levels at later stages (P90) 
(Fig. 22B).
A
Figure 22. Inflammatory response in AEC conditional mouse
model. A) mRNA levels of different inflammatory mediators in 
mutant skin at P8. B) Systemic accumulation of IgE (ng/ml) in blood
serum of mutant mice at adult stage (P90) measured by ELISA (***P-
value=0.001; n=16).
4.6 Autoimmune condition associated with AEC syndrome
AEC mutant mice had high white blood cells (WBC) counts (>15.000 cells/μl)




























Figure 23. White blood cell counts in L514F mice and relatives 
controls: increase of WBC count in L514F animals measured at P16
(***P-value= 0.0003; n=8).
Since Tslp is able to reach the bloodstream and to influence the cell fate of 
different inflammatory and immune cell populations (Liu et al, 2007), the 
hematopoietic organs bone marrow and spleen were analysed.
Flow cytometry (FACS) analysis of bone marrow (BM) and spleen cells 
demonstrated a clear expansion of pre- (B220+ CD43- IgM-) and immature B 
cells in both central and peripheral compartments of the mutant mice (Fig. 24A
and B). The expansion of Pre- and Immature B Cells caused a B-
Lymphoproliferative Disorder (B-LPD) including B-cell infiltration into vital 
organ in AEC mice that could culminate in death, consistent with previous 
reports (Astrakhan et al, 2007) (Demehri et al, 2009b).
Figure 24. Expanding Pre- and Immature B cells cause a B-LPD in 
the mutant animals. Mature and immature B-lymphocytes were 
measured by FACS analysis in bone marrow (***P-value= 7.76267E-




(Fig. 24B) in mice at P10. Increased CD43-IgM-B220+ revealed an
enrichment in Pre-B cells in mutant mice.
4.7 Generation of AEC conditional mouse model in a Tslp null 
background
To evaluate whether the absence of Tslp in AEC conditional mouse model may 
lead to a reduced inflammatory state, AEC mice (L514F) were crossed with
Tslp floxL2/floxL2 conditional null mice (Tslp epidermal Knock-out Tslp eKO)
(Li et al, 2009). Also the deletion of Tslp occurred in epidermis thanks to CRE 
recombinase (K14-Cre ΔNeo) and gave birth to L514F; Tslp eKO (Fig. 25B).
At P0 L514F; Tslp eKO showed small and large areas of focal blistering in the 
basal layer (Fig. 25A), as we observed in L514F skin mice. Accordingly with 
the previous model, at P3 L514F; Tslp eKO are characterized also by a 
reduction of Krt10 and Krt15 at mRNA levels (Fig. 25B) suggesting that Tslp 




Figure 25. L514F; TSLPeKO histological analysis at P0 and keratin 
levels expression at P3 A) H&E staining of the skin from newborn 
mice reveals blistering between the basal lamina and the basal layer and 
between basal layer and suprabasal compartment in L514F;TSLPeKO
skin but not in wild-type epidermis at birth, as reported for L514F mice. 
B) Real time RT-PCR for Tslp (Tslp ***P-value=0.000492162; n=14)
in mouse epidermis derived from +/+; L514F and L514F; TSLPeKO
mice confirmed the deletion of Tslp in epidermis of L514F;TSLPeKO
mice. Real time RT-PCR for Krt10 and Krt15 reveals a downregulation 
for both keratins in L514F;TSLPeKO mice similarly observed in L514F 
mice (Krt10 **P-value= 0.008484229; n=6; Krt15 **P-
value=0.000408351; n=6).
Interestingly, at P8 L514F; Tslp eKO didn’t show shallow erosion or crusting, 
as we observed at the same stage in L514F mice (Fig 26A). Furthermore, we 
observed that L514F; Tslp eKO at P10 displayed an higher survival compared
to L514F. In addition L514F; Tslp eKO presented a body weight at similar 
level of wild type controls (Fig 26B and C).
At P40 L514F; Tslp eKO showed a delayed hair loss, a milder phenotype 
compared to L514F mice,, no erythema, no crusting and an amelioration of 




Figure 26. Characterization of conditional L514F; TSLPeKO mice:
phenotype, survival and weight. A) Photographs are taken from 
+/+,+/L514F and L514F;TSLPeKO mice at 8 days. B) Survival curve 
of L514F; TSLPeKO (green line), L514F (black line), and +/+ (red
line) mice (*P-value=0.018; n=80). C) Body weight at P10 of +/+, 
L514F and L514F; TSLPeKO. D) Photographs are taken from L514F
and L514F; TSLPeKO mice at 40 days (P40).
4.8 Test the contribution of Tslp upregulation and inflammation in L514F;
TSLPeKO conditional mice 
The deletion of Tslp occurred in epidermis and reduced the severity of 
inflammation at P8 in the skin of L514F; TSLP eKO animals. Indeed, normal
epidermal and dermal thickness (Fig. 27A), and the proper expression of Krt6
was observed in L514F; TSLPeKO mice (Fig. 27A). Also the immunostaining 
for CD-45 showed the reduction of leukocytes infiltration in L514F; TslpeKO
mice skin and Ki-67 immunofluorescences showed a normal proliferation in
AEC mouse model with a Tslp null background. Furthermore, macrophages
and mast cells are expressed as in the control mice thus indicating an 





Figure 27. Rescue of the inflammatory state in L514F mice with a 
Tslp null background A) H&E staining of dorsal skin of L514F;
TslpeKO mice at P8. L514F; TslpeKO epidermis is similar to controls. 
Ki-67 staining in the epidermis of L514F; TslpeKO mutant mouse
presented no difference compared to controls. Immunofluorescence
analysis for Krt6 in skin at P8 revealed its properly localization in
L514F; TslpeKO epidermis. B) Immunofluorescence analysis for CD45 
in skin at P8 showed no difference between L514F; TslpeKO and 
control animals. Immunofluorescence analysis for F4/80 in skin at P8 
also showed no difference between L514F; TslpeKO and relative 
controls. Histological analysis of mast cells with toluidine blue staining 




The inflammatory response mediated by inflammatory cytokines and AMPs is 
also attenuated confirming that Tslp is involved in the insurgence of the 
inflammatory process and that inflammation occurred as secondary condition 
associated with AEC syndrome (Fig. 28).
Figure 28. Rescue of the inflammatory cytokines and AMPs in 
L514F mice with a Tslp null background. mRNA levels of different 
inflammatory mediators in skin of L514F; TSLPeKO at P8 reveal the 
attenuation of the inflammatory response (red arrows) in L514F in a 
Tslp null background. 
Consistent to these results in bone marrow of L514F; TSLPeKO mice B-cell
development and maturation was not affected, pre-B cells developed normally 
and spleen size was equal to wild type mice, confirming the rescue in L514F


























Figure 29. Rescue of the pre-B lymphocytes in spleen of L514F;
TSLPeKO mice. B-lymphocytes maturation was measured by FACS 
analysis in spleen at P10. A rescue of the distribution between
immature and mature B-cells was observed in L514F; TSLPeKO mice 
compared to L514F (CD43-, B220+: P-value <0.001***; n=10; IgM-,
B220+: P-value= <0.001***; n=12). 
4.9 Klks/PAR2/NFAT pathway regulates Tslp expression in AEC 
syndrome
Microarray data revealed us that kallikreins, enzymes with serine protease 
activity that regulate the desquamation of the epidermis (Candi et al, 2005)
were strongly up-regulated at P3 thus indicating an altered equilibrium in 
epidermis structure (Fig. 30). In particular, Klk6 is the proteases most induced 
in AEC mutant mice compared to wild type. 
Figure 30. Gene expression analysis. Microarray data showed that a 
subset of kallikrein proteases were up-regulated in AEC mutant mice.
BONE MARROW 
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Recently calcineurin/NFAT signaling has been implicated in Tslp expression 
downstream of the PAR2 receptor (Wilson et al, 2013). PAR2 activation by 
serine proteases such as kallikreins (KLKs) leads to calcineurin-dependent
nuclear translocation of the transcription factor NFAT. In AEC mouse 
epidermis at P3 protease activity was induced as determined by in situ 
zymography (Fig. 31; in collaboration with A. Hovnanian).
Figure 31. Proteolytic activity in AEC mutant epidermis.  In situ gel
zymography with casein as substrate demonstrate a strong induction of 
serine-protease protein activity in L514F mutant mice at P3.
Interestingly at P3 we confirmed the microarray data and observed that Klk6
mRNA and to a lesser extent Klk10 was strongly upregulated as compared to 
controls (Fig. 32A). These data were confirmed also by the 
immunofluorescence staining for Klk6 (Fig. 32B) and by protein levels (Fig.
32C). We observed a specific upregulation of Klk6 by western blot analysis, 
instead Klk5 and Klk7 protein levels are expressed equally in L514F mouse 






























Figure 32. Klk6 upregulation in L514F mice. A) Relative mRNA 
expression of the indicated kallikreins shows a strong upregulation of 
Klk6 in the epidermis of L514F mutant mice at P3. B) Immunoblotting
analysis for the indicated proteins in cell extracts of mouse epidermis 
derived from mutant and control mice at P3. Data are normalized for b-
actin protein expression. C) Immunofluorescence analysis for 
Klk6/p63 in skin at P3 shows the strong upregulation of Klk6 in the 
stratum corneum of the epidermis of L514F mice compared to control
animals.
p63 may directly regulate Klk6 since p63 depletion in keratinocytes leads to 
increase Klk6 expression (Fig. 33A). In vivo, in AEC mutant epidermis we
observed at P3 that NFAT is highly expressed compared to wild-type (Fig.
33C). NFAT overexpression triggers Tslp induction in mouse keratinocytes 
(Fig. 33B), supporting the hypothesis that the axis KLK/PAR2/NFAT signaling 












Figure 33. Klk6 upregulation in L514F mice. A) Klk6 mRNA levels 
is upregulated upon p63 depletion (P-values: <0.05 *; <0.01 **; <0.001 
***; n=8). B) Tslp mRNA is induced by a constitutive active form of 
NFAT. C) Immunofluorescence analysis for NFAT/Krt14 in skin at P3
shows the presence of NFAT in the basal layer of the epidermis of 





AEC syndrome is an autosomal dominant disorder characterized by cleft 
palate, ectodermal dysplasia, and severe skin fragility and extensive erosions 
that are currently treated using generic wound care. Targeted treatments are
highly desirable. The disorder is caused by mutations in the p63 gene, coding 
for a transcription factor that is a master regulator of epidermal structure and 
function. AEC mutations lead to reduced mechanical strength by affecting 
desmosome and keratin expression, and causing severe skin inflammation. 
Most AEC causative mutations fall in the poorly characterized C-terminal
domain of the p63 alpha isoform not shared by p63 beta. 
Since little is known about the causes of AEC skin erosions, the histological
and molecular defects, we previously generated a constitutive mouse model 
that carries a clinically relevant point mutation in the SAM domain of the p63 
alpha isoform (L514F) reported in AEC patients.
p63+/ L514F mice died at birth with severe cleft palate, skin defects and 
ectodermal dysplasia (Ferone et al, 2012), thus faithfully recapitulating the 
defects observed in AEC syndrome. The cause of death in p63+/ L514F mice was
cleft palate, which is lethal in mice but not in humans. p63+/ L514F skin
displayed an overall reduction in skin thickness, accompanied by a significant 
epidermal atrophy and hair follicle hypoplasia. At the molecular level we 
found that the AEC mutation affected proliferation of the epithelial cells of the 
palate and skin, and led to a reduced number of epidermal stem cells. These 
phenotypes were associated with aberrantly low FGF signaling due to reduced 
expression of the FGF receptor Fgfr2, a direct p63 target gene. Importantly, we 
obtained evidences that humans affected by AEC syndrome have similar 
defects of the epidermal stem cell compartment (Ferone et al, 2012). AEC
mouse skin displayed focal blistering skin lesions, localized mainly between 
the basal and suprabasal layers of the epidermis accompanied with acantholysis 
(loss of intercellular adhesions) and only rarely by cytolysis (rupture of the cell 
membrane). These phenotypes were associated with reduced desmosomal 
contacts in AEC mutant skin. We demonstrated that skin fragility observed in 
the constitutive mouse model was caused by a strong reduction of desmosomes 
and that Dsg1, Dsc3 and Dsp were strongly reduced also in human 
keratinocytes derived from AEC patients and focal downregulation of DSP and 
DSC3 expression was observed in non-lesional skin of AEC patients (Ferone et 
al, 2013; Koster et al, 2014), confirming their possible causative role in the 
pathogenesis of AEC syndrome.
To overcome the lethality of the constitutive mouse model and to better 
characterize the molecular mechanisms underlined skin erosions and 
hypothetical in vivo treatments, we generated a conditional AEC mouse model. 
The conditional knock-in model (p63+/floxL514F) expresses the L514F mutation 
only in the presence of the CRE recombinase. Thus the newly generated 
p63+/floxL514F mouse model expresses only the wild-type p63 and has no 
phenotype until a portion of the inserted DNA is removed by CRE-mediated
? ????
recombination.  We cross p63+/floxL514F with a knock-in mouse expressing Cre 
by E17.5 in epidermis and hair follicle under the control of the endogenous 
Keratin 14 (K14) promoter (K14-Cre ∆neo) to obtain both the heterozygous 
and the homozygous model (+/L and L/L) (Huelsken et al, 2001).
We begin to characterize the heterozygous model, +/L that show no gross
abnormalities. We hypothesize that, since the expression of the mutation is late 
in the development a number of biological processes that required p63 
presence are not affected because they happen when the mutation is still off
and only one copy of mutant p63 is not able to negatively influence these
processes later. Our observations are quite in contrast with what we observe in
the constitutive model, in which gene expression analysis lead us to 
hypothesize that L514F mutation acts in a dominant negative fashion. To shed 
light on this discrepancy further analysis on the molecular mechanisms by 
which mutant p63 influences its transcriptional activity will be needed. On the 
other hand it has been reported that sometimes mouse model and human 
disorders are quite different in the genetic contest, therefore our model need to 
be in homozygosity to mimic the syndrome. Importantly, alteration of the p63 
target genes in the conditional homozygous model is comparable to the 
constitutive heterozygous mutant in spite of nearly complete absence of the 
wild-type copy by P0, thus indicating that the L/L model is comparable to the 
constitutive one.
The conditional mouse model for AEC syndrome (L514F) is affected by a 
progressive skin phenotype characterized by focal skin erosions and scaling, 
skin crusting and hair loss, closely resembling the skin defects observed in 
humans affected by AEC syndrome. The severe skin phenotype leads to 
reduced body weight and survival. Histological analysis of newborn skin 
reveals focal disruption of cell-cell adhesion, as previously observed for the 
constitutive mouse model (Ferone et al, 2013) and cytolysis of the basal layer, 
even in the absence of a macroscopic phenotype. Consistent with local areas of
mechanical disruption, focal loss of epidermal barrier is observed. 
Ultrastructural analysis demonstrated reduced keratin bundles in the basal layer
of the epidermis, accompanied by reduced expression of several keratins, of 
which Krt5 and Krt15 are the most severely affected. Importantly reduced Krt5
and Krt15 are observed also in human samples derived from AEC patients at 
the RNA and protein levels (Ferone et al, 2012).
Few days after the first biochemical sign of inflammation, AEC mutant 
epidermis becomes hyperplastic and hyperkeratotic with neutrophils 
accumulation in the epidermis, Krt6 induction and massive infiltration of 
macrophages and mast cells in the dermis. Blister healing often involves the 
induction of keratins related to Krt5 (Krt6a and Krt6b) and Krt14 (Krt16 and 
Krt17) (Coulombe et al, 2009). By P3, Krt6 and Krt16 are strongly 
upregulated, whereas Krt17 is unaffected, suggesting a partial and selective 
compensation. Concomitant with Krt6 and Krt16 induction, we observed 
significant induction of damage-associated molecular pattern molecules 
(DAMPs) that initiate the inflammatory response in the event of a disruption of 
? ????
the epidermal barrier, such as the inflammatory complex calprotectin (S100a8/ 
S100a9 complex), and -to a lesser extent- antimicrobial peptides (Defb). In
addition, we observed massive upregulation of thymic stromal lymphopoietin 
(Tslp), an interleukin 7-like cytokine, which is markedly elevated in lesional 
skin of atopic dermatitis and asthmatic patients (Ziegler & Artis, 2010). TSLP 
is produced by epithelial cells and causes a polarization of dendritic cells to 
drive T helper (Th) 2 cytokines production. TSLP also directly promotes T-cell
proliferation in response to T-cell receptor activation and Th2 cytokine 
production, and supports B-cell expansion and differentiation. TSLP further 
amplifies Th2 cytokine production by mast cells and natural killer T cells. 
Several observations support the notion that TSLP is implicated in 
autoimmunity, promoting humoral autoimmunity by enhancing B cell 
population expansion (Astrakhan et al, 2007), indicating that signaling 
pathways triggering Tslp expression and their inhibitors may have therapeutic 
potential in a number of diseases. Consistently, massive Tslp induction 
precedes skin inflammation and is released into the blood circulation, likely 
causing the development of a B-Lymphoproliferative Disorder with massive 
increase of pre-B cells in the bone marrow and in the spleen as observed by 
Demehri et al, in Notch1; Notch2 conditional knock-out mice (Demehri et al, 
2008).
The consequence of ablating Tslp was evaluated by crossing AEC mutant 
mice with conditional Tslp null mice (Li et al., 2009). Genetic ablation of Tslp 
in the epidermis of L514F mice ameliorates the general health condition of 
AEC mutant mice, significantly increasing survival, and reducing skin 
inflammation. Importantly deletion of Tslp in the epidermis is sufficient to 
rescue B-cell maturation. Taken together these data indicate that Tslp is likely 
to be a crucial mediator of skin and systemic inflammation in AEC syndrome. 
Several pathways may be responsible for Tslp induction downstream of mutant 
p63. To begin to untangle the pathways regulating Tslp downstream of p63, we 
tested the following hypothesis: 2) Calcineurin/NFAT regulates Tslp
expression in AEC syndrome. Calcineurin/NFAT signaling has been recently 
implicated in Tslp expression downstream of the PAR2 receptor (Wilson et al., 
2013). PAR2 activation by serine proteases such as kallikreins (KLKs) leads to 
calcineurin-dependent nuclear translocation of the transcription factor NFAT. 
In AEC mouse epidermis at P3 Klk6 mRNA (and to a lesser extent Klk10) is 
strongly upregulated as compared to controls. We demonstrated that p63 might
directly regulate Klk6 since p63 depletion in keratinocytes leads to increase 
Klk6 expression. In agreement with Klk6 upregulation, protease activity is 
induced in AEC mouse skin as determined by in situ zymography (Fig. 14D; in 
collaboration with A. Hovnanian). Furthermore we observed that NFAT
overexpression triggers Tslp induction in mouse keratinocytes, supporting the 
hypothesis that the axis KLK/PAR2/NFAT signaling may be involved in 
aberrant overexpression of TSLP in AEC syndrome. 
Being AEC syndrome a rare disorder with variable penetrance, extensive 
studies in patients have not been performed. However, we observed that TSLP 
? ????
expression in the epidermis of AEC patients is doubled as compared to control 
individuals. Interestingly, an autoimmune disorder has been observed in at 
least one AEC patient with severe skin erosions occurring soon after birth in 
70% of the body, indicating that the release of TSLP may be at basis of a 
systemic autoimmune condition also in individuals affected by AEC syndrome. 
This patient during the childhood was placed under prednisone, and at the age 
of 16 is still on a very low dose of mycophenolate mofetil (M. Atlas, MD 
Pediatric Hematology-Oncology doctor; personal comm.). We tested his levels 
of TSLP in the blood, but found no difference with matching controls, 
consistent with the remission of the disease. We are in the process of obtaining 
approval for systematic examination of blood levels of TSLP in AEC children, 
with the help of the American National Foundation for Ectodermal Dysplasia 
(NFED) to coordinate the enrollment of patients since the largest collection of 
families affected by AEC syndrome is done in the US. 
Pharmacological Tslp inhibitors are not available yet, however identification of 
molecular pathways leading to Tslp induction in epidermis may help to identify 
specific inhibitors of upstream pathways. Several other pathways beyond the 
calcineurin/NFAT pathway may be responsible for Tslp induction downstream 
of mutant p63 such as the Notch signaling pathway or the NF-kB. In addition, 
other molecules such as the transcription factors NF-kB, AP-1, as well as the 
Ca2+-permeable ion channel TRPRV1 could be part of the Tslp regulation and 
they have to be analyzed. Understanding the pathways regulating Tslp 




In conclusion, we have demonstrated that the basal cell fragility and 
blistering observed in AEC mutant mice are due to alteration in adhesion 
molecules belonged to different categories. Interestingly, we have established a
key role of intermediate filaments in the basal layer of the epidermis of AEC 
mouse model, which integrity is fundamental to give mechanical resilience to 
the epidermis. For the first time we have evaluated the contribution of Krt5 in 
the progression of skin erosions in AEC syndrome therefore paving the way for 
new feasible treatments aimed at restoration of keratins functionality. 
Importantly, we have explored the possibility that altered skin barrier due to 
unbalanced keratin bundles in the basal layer leads to inflammation, driven by 
upregulation of Tslp. TSLP is at basis of a systemic autoimmune condition also 
in individuals affected by AEC syndrome. Genetic ablation of Tslp in the 
epidermis of L514F mice ameliorates the general health condition of AEC 
mutant mice. Mechanistically, massive Tslp induction was accompanied by 
strong induction of kallikrein-6 (Klk6) and NFAT accumulation in mutant
epidermis. We have demonstrated that p63 might directly regulate Klk6 since 
p63 depletion in keratinocytes leads to increase Klk6 expression. Overall in
AEC mutant epidermis, Klk6 upregulation leads to massive Tslp induction by 
an NFAT-dependent mechanism (Fig. 34). In addition, other molecules such as 
the transcription factor NF-kB could be part of the Tslp regulation and they 
have to be analyzed. 
Taken together these data indicate that Tslp is likely to be a crucial 
mediator of skin and systemic inflammation in AEC syndrome, and controlling
Tslp in severely affected patients may be therapeutically beneficial.
Figure 34. Proposed model: Tslp regulation and mechanism of 
action in keratinocytes. Proposed model for Tslp regulation by p63 
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Research Techniques Made Simple: Skin
Carcinogenesis Models: Xenotransplantation Techniques
Maria Rosaria Mollo1, Dario Antonini2, Luisa Cirillo1,3 and Caterina Missero1,4
Xenotransplantation is a widely used technique to test the tumorigenic potential of human cells in vivo using
immunodeﬁcient mice. Here we describe basic technologies and recent advances in xenotransplantation
applied to study squamous cell carcinomas (SCCs) of the skin. SCC cells isolated from tumors can either be
cultured to generate a cell line or injected directly into mice. Several immunodeﬁcient mouse models are
available for selection based on the experimental design and the type of tumorigenicity assay. Subcutaneous
injection is the most widely used technique for xenotransplantation because it involves a simple procedure
allowing the use of a large number of cells, although it may not mimic the original tumor environment. SCC cell
injections at the epidermal-to-dermal junction or grafting of organotypic cultures containing human stroma
have also been used to more closely resemble the tumor environment. Mixing of SCC cells with cancer-
associated ﬁbroblasts can allow the study of their interaction and reciprocal inﬂuence, which can be
followed in real time by intradermal ear injection using conventional ﬂuorescent microscopy. In this article, we
will review recent advances in xenotransplantation technologies applied to study behavior of SCC cells and
their interaction with the tumor environment in vivo.
Journal of Investigative Dermatology (2016) 136, e13ee17; doi:10.1016/j.jid.2015.12.015
INTRODUCTION
Establishing human tissue cancer models is essential to
elucidate fundamental mechanisms underlying cancer
development and progression, and to develop novel thera-
pies. Humanized mouse models, in which human tumor cells
or tissue are engrafted into immunodeﬁcient mice (xeno-
transplantation), are frequently used to understand tumor
biology in the presence of a tissue environment, and to study
tumor responses to gene modulation and pharmacological
treatments in vivo.
This article will focus primarily on xenotransplantation
models for skin squamous cell carcinomas (SCCs). In
most cases, this process involves growth in culture of
neoplastic keratinocytes or genetically modiﬁed kerati-
nocytes, ﬁbroblasts, and other skin cell types that can be
admixed with keratinocytes and used for in vivo tissue
regeneration.
To establish SCC cell lines, primary tumor tissue is
physically dissociated into either small explant pieces or
single cell suspensions to be expanded in culture on a
feeder layer of 3T3 ﬁbroblasts, but SCC cells soon become
feeder independent (Purdie et al., 2011). Deﬁned genetic
lesions contributing to SCC formation, such as proto-
oncogene or tumor suppressor mutations, can be studied
by manipulating human primary keratinocytes using retro-
viral- or lentiviral-mediated gene modulation (Khavari,
2006), allowing the introduction of putative oncogenes,
knockdown of tumor suppressor genes, or gene ablation or
mutation using genome editing tools such as the CRISPR/
Cas9 system.
BENEFITS
 Allows measurement of the tumorigenic
potential of human skin cancer cells in a
complex in vivo environment.
 Allows study of the consequences of speciﬁc
genetic alterations in vivo.
 Canbeused for screening the therapeutic potential
of novel chemical compounds on human tissues.
 Interactions between epithelial tumor cells,
stroma, and other cell types can be studied in
combination.
 Recent techniques allow growth of primary SCC
tissue and SCC single-cell suspensions, and/or
monitoring growth in real time using in vivo
imaging.
LIMITATIONS
 Only partially recapitulates tumor organization
and function, and its interaction with the im-
mune, vasculature, and lymphatic systems.
 As with other in vivo assays, it is subject to high
variability, and appropriate statistical analyses
must be used to obtain reliable results.
 Tumor development occurs slowly, and may take
up to or more than 4 months.
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 RESEARCH TECHNIQUES MADE SIMPLE
IMMUNODEFICIENT MOUSE MODELS FOR
XENOTRANSPLANTATION
Immunodeﬁcient mouse strains are used for human cell
studies to avoid rejection of the human cells. Here we will
focus on immunodeﬁcient mouse models that have been used
in dermatological research for studying SCC (for a more
comprehensive description of recipient mouse strains, see
Russell et al., 2015). Athymic Foxn1nu (nude) mice lack
functional T cells, but have an intact humoral adaptive and
innate immune system (Price, 2014). In spite of only partial
impairment of the immune system, nude mice effectively
support tumor growth because of a paradoxical role of both
the adaptive and innate immune responses in inducing
inﬂammation, which can be protumorigenic (Patel et al.,
2012). In severe combined immune deﬁciency (SCID) mice,
the development of mature T- and B-lymphocytes is abol-
ished, but innate immunity is conserved. Similarly, RAG1/2
null mice lack both functional T and B cells. Crossing SCID
mice with nonobese diabetic (NOD) mice confers partially
defective innate immunity. To further weaken the innate im-
mune system, immunodeﬁcient mice carrying a targeted
mutation in the IL2 receptor common gamma chain gene
(IL2r g) have been crossed with NOD/SCID or NOD/RAG1/2
mice, generating the NOD/SCID/IL2r g null or NOD/RAG1/2/
IL2r g null mice. Adaptive immunity is completely lacking in
NOD/SCID/IL2r g null and NOD/RAG1/2/IL2r g null mice,
and they are severely deﬁcient in innate immunity, thus being
highly receptive to the engraftment of human cells, tissues,
and primary tumors.
INJECTIONS OF HUMAN CELLS IN
IMMUNODEFICIENT MICE
The most widely used tumorigenicity assay involves
ectopic injection of neoplastic cells into the subcutaneous
space on the back of immunodeﬁcient mice. Depending
on the experimental design, tumor cells and relative controls
are frequently injected into the two dorsal ﬂanks to
compare their tumorigenicity in the same biological
environment.
A range of 0.5  105 to 5  106 tumor cells are injected,
depending on their tumorigenic potential and the experi-
mental plan. A smaller number of cells can be utilized when
testing the tumor-initiating capability of selected cell pop-
ulations. In this case, it is crucial to use NOD/SCID/IL2r g null
mice where adaptive immunity is completely lacking,
because a small number of cells are more prone to be
destroyed by the immune system. In addition, tumorigenic
cells are mixed with Matrigel, a complex mixture of extra-
cellular matrix proteins that enhances the engraftment of
primary epithelial cancer cells by promoting perfusion of
nutrients and holding cells in place in the subcutaneous tissue
(Quintana et al., 2008). Matrigel is used at a high concen-
tration (20 mg/ml) with the cells mixed in a 1:1 ratio. After
injection, tumor size is monitored once a week, and two
diameters of the tumors are measured to estimate changes in
tumor volume over time. Immunohistological and immuno-
histochemical analysis is required to determine the tumor
grade by examining tissue morphology, degree of cell pro-
liferation, differentiation, and number of cells undergoing
senescence or apoptosis.
ADVANCES IN SCC XENOTRANSPLANTATION
Established SCC cell lines are mostly tumorigenic and retain
features of primary cutaneous SCC with variable degree of
differentiation, ranging from well-differentiated cysts to more
aggressive tumors, whereas grafting of freshly isolated SCC
cells is more challenging. Recently, Patel et al. (2012)
established a method to obtain reproducible and robust
growth of xenografted primary SCC tissue and SCC single-cell
suspensions in athymic nude mice by preimplantation of a
humanized stromal bed. In this assay, a glass disk or Gelfoam
dressing is implanted into the dorsal subcutaneous space,
together with 106 primary human dermal ﬁbroblasts (HDFs)
suspended in Matrigel. After 2 weeks, the glass disk is
removed and intact tumor tissue or primary human SCC cells
suspended in Matrigel are injected into the subcutaneous
space or into the in situ Gelfoam dressing (Patel et al., 2012).
The glass disk promotes a stromal reaction and vasculariza-
tion sufﬁcient to induce reproducible tumor growth from SCC
cell lines. However, preimplantation of HDFs is essential to
achieve robust growth of primary SCC cells. With this
method, xenografts from all tumor grades maintain the his-
tological and growth characteristics of the original tumors
even through serial transplantation (Figure 1). Interestingly,
xenografts of freshly isolated SCC cells are consistently larger
in athymic nude mice than in more immunocompromised
mice (SCID), possibly due to a higher inﬂammatory response
elicited in athymic nude mice, in which only T cells are
compromised, but the humoral and innate responses are still
active.
Subepidermal injections
Although subcutaneous injections are widely used, the sub-
cutaneous microenvironment is different from the one in
which skin tumors originally develop. To promote the inter-
action of cancer cells with a more physiological environment,
SCC cells can be mixed with Matrigel and injected at the
dermal-epidermal junction. An advantage of this technique is
that SCC cells diffuse less, and proliferative centers originating
from single cells can be counted (Wu et al., 2010). Although
injecting in the subepidermal environment is insufﬁcient to
enhance SCC tumorigenic potential, it can be useful to test
cancer-inducing factors. Indeed, using this assay, Wu and
co-workers demonstrated that inhibition of the calcineurin/
nuclear factor of activated T-cell pathway induced a more
aggressive, moderately inﬁltrating tumor phenotype with high
cellularity, thus suggesting a reason for why treatment with
calcineurin inhibitors, used as immunosuppressive treatment
for organ transplantation recipients, leads to an increased risk
of SCC formation.
Ear injections
More recently, Procopio et al. (2015) described a novel
assay for studying SCC and stromal cell expansion by
intradermal ear injection in NOD/SCID/IL2r g null mice.
The ear thinness enables tumor formation to follow in real
time and quantiﬁcation of its growth rate by in vivo
imaging using conventional ﬂuorescence stereomicroscopy
(Figure 2). A very low volume can be injected, allowing a
low number of cells (105) to be used. This novel technique
has proven useful to test the function of the Notch effector
RESEARCH TECHNIQUES MADE SIMPLE 
Journal of Investigative Dermatology (2016), Volume 136e14
(suppressor of hairless or RBP-J in mammalian cells) CSL in
the stromal component of the tumor. The expansion of
SCC13 cells admixed with HDFs depleted for CSL, p53, or
both was monitored in time. Cancer cell expansion was
signiﬁcantly enhanced in the presence of HDFs with
concomitant silencing of CSL and p53, as compared with
CSL or p53 alone. Interestingly, stromal cells themselves
missing both CSL and p53 expanded to a much greater
extent than those with silencing of CSL alone. Thus, loss or
reduction of CSL in HDFs coupled with p53 inactivation
induces SCC expansion, demonstrating a crucial contribu-
tion of stromal CSL in tumor formation. Similar to the ob-
servations obtained by Patel et al. (2012), these ﬁndings
demonstrate a fundamental role of the stroma in SCC
expansion.
Grafting of human engineered skin
To study speciﬁc genetic contributors to SCC, genetic
manipulation of primary human keratinocytes using high-
efﬁciency gene transfer can be achieved using retroviral in-
fections repeated at 8- to 12-hour intervals in rapidly dividing
cells (Lazarov et al., 2002), which can then be seeded
onto devitalized human dermis containing extracellular
matrix and stromal proteins (Khavari, 2006). In contrast to
subcutaneous or subepidermal injections where an underly-
ing extracellular matrix and intact epithelial basement
membrane is lacking, this method allows reconstitution of a
human skin-like environment, although it does not fully
recapitulate the stochastic nature of mutations that occur in
spontaneous cancers and the genomic instability typical of
most human cancers.
Recently, Monteleon et al. (2015) used this model to
study the function of the protein domains of the IQ
motif-containing GTPase-activating protein (IQGAP1), a
modulator of mitogen-activated protein kinase signaling,
using exogenous expression of IQGAP1 decoy peptides. Ras/
CDK4 transformed keratinocytes were infected with lentivi-
ruses designed to drive expression of a single IQGAP struc-
tural domain to interfere with speciﬁc IQGAP functions.
Using this model, a single decoy peptide designed to interfere
with binding to the Ras effector Raf (IQGAP-IQM) was found
to signiﬁcantly suppress tumor formation and mitogen-
activated protein kinase phosphorylation (Figure 3), whereas
the other peptides were ineffective.
CONCLUDING REMARKS
In conclusion, xenotransplantation represents a unique tool to
study human SCC progression in an in vivo environment.
Recent advances in this technique focus on reproducing the
Figure 1. Xenografts from cell suspensions can accurately recapitulate human squamous cell carcinoma (SCC). (a) Schematic of the technique. (b) SCC
xenografts from cell suspensions recreated the original tumor morphology and (c) growth based on the original tumor histological grade. Reprinted with
permission from Patel et al. (2012).
Figure 2. Tumor and stromal cell expansion in an ear injection assay.
(a) DsRed2-expressing SCC13 cells were admixed with green ﬂuorescence
protein-expressing human dermal ﬁbroblasts (HDFs), followed by injection
into mouse ears and imaging every 2e3 days under a ﬂuorescence dissection
microscope. Shown are representative images from a mouse ear at the
indicated times after injection. (b) Quantiﬁcation of digital images for relative
red (SCC cells) ﬂuorescence intensity values (intensity  surface area) at
different days after injections. SCC, squamous cell carcinoma. Photo courtesy
of G.P. Dotto and M.G. Procopio.
www.jidonline.org e15
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tumor microenvironment and following tumor growth in real
time. In the future, engineered human skin and subepidermal
and ear injections may become increasingly useful for pre-
clinical investigations of novel therapies, because these
models are amenable to topical treatments.
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Figure 3. Expression of the IQGAP1-IQM decoy peptide inhibits invasive
squamous cell carcinoma (SCC). (a) IQGAP1-IQM expression inhibits
keratinocyte proliferation and invasion in an SCC skin xenograft, bar ¼
250 mm. (b) Relative tumor cross-sectional area of xenograft control versus
IQGAP1-IQM SCC tumors. (c) MAPK signaling as indicated by phospho-ERK
expression is markedly diminished in the IQM-expressing tissue, bar ¼
100 mm. ERK, extracellular signal-regulated kinase; IQGAP; IQ
motif-containing GTPase-activating protein; MAPK, mitogen-activated protein
kinase. Reprinted with permission from Monteleon et al. (2015).
MULTIPLE CHOICE QUESTIONS
1. Which of the following murine models is more




C. NOD/SCID/IL2rg null (NSG)
D. Athymic Foxn1nu (nude)
2. Are SCC cells highly tumorigenic when used in
xenotransplantation assays?
A. SCC cells are less tumorigenic when injected
with human dermal ﬁbroblasts
B. SCC cells form aggressive tumors when
injected at high concentration
C. SCC cells form aggressive tumors when
injected in the ear
D. Freshly isolated SCC cells are not highly
tumorigenic when injected subcutaneously
in nude mice without a stromal bed
3. Which of the following sentences is false?
A. Subepidermal injections enhance SCC
tumorigenic potential and can be used to test
cancer inhibiting small compounds
B. Ear injections can be used to monitor
expansion of tumorigenic cells in real time
using conventional ﬂuorescence
stereomicroscopy
C. In subcutaneous injections, the presence of
human dermal ﬁbroblasts enhances tumor
growth of human SCC primary cells
D. Grafting of human engineered skin onto mice
reconstitutes a human skin-like environment
4. What is the advantage of injecting SCC cells in
the subepidermal compartment?
A. Allows injection of a low number of cells
B. Allows interaction of cancer cells with a more
physiological environment
C. Induces a higher inﬂammatory response
D. Promotes rapid tumor growth
5. Why does preimplantation of a glass disk or
Gelfoam improve tumorigenicity of SCC cells in
subcutaneous injections in nude mice?
A. It generates a wound-like environment,
allowing easier access for implantation of
SCC cells
B. It induces secretionofT-lymphocyteesecreted
chemokines, thus favoring tumor growth
C. It allows the SCC cells to grow more
efﬁciently in clusters
D. It creates a favorable environment by
generating a stromal reaction
This article has been approved for 1 hour of Category 1 CME credit.
To take the quiz, with or without CME credit, follow the link under
the “CME ACCREDITATION” heading.
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